<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="efs2e200915" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">EFSA J</journal-id><journal-id journal-id-type="iso-abbrev">EFSA J</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1831-4732</journal-id><journal-id journal-id-type="publisher-id">EFS2</journal-id><journal-title-group><journal-title>EFSA Journal</journal-title></journal-title-group><issn pub-type="epub">1831-4732</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9749437</article-id><article-id pub-id-type="doi">10.2903/j.efsa.2022.e200915</article-id><article-id pub-id-type="publisher-id">EFS2E200915</article-id><article-categories><subj-group subj-group-type="overline"><subject>Eu&#x02010;fora Series 5</subject></subj-group><subj-group subj-group-type="heading"><subject>Eu&#x02010;fora Series 5</subject></subj-group></article-categories><title-group><article-title>Microbiota analysis for risk assessment of xenobiotics: toxicomicrobiomics, incorporating the gut microbiome in the risk assessment of xenobiotics and identifying beneficial components for One Health</article-title><alt-title alt-title-type="right-running-head">Exploring the gut microbiome under One Health</alt-title></title-group><contrib-group><contrib id="efs2e200915-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ampatzoglou</surname><given-names>Antonios</given-names></name><xref rid="efs2e200915-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>eu-fora@efsa.europa.eu</email></address></contrib><contrib id="efs2e200915-cr-0002" contrib-type="author"><name><surname>Gruszecka&#x02010;Kosowska</surname><given-names>Agnieszka</given-names></name><xref rid="efs2e200915-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="efs2e200915-cr-0003" contrib-type="author"><name><surname>Aguilera&#x02010;G&#x000f3;mez</surname><given-names>Margarita</given-names></name><xref rid="efs2e200915-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="efs2e200915-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">"Jos&#x000e9; Mataix Verd&#x000fa;" Institute of Nutrition and Food Technology</named-content>
<institution>University of Granada (INYTA&#x02010;UGR)</institution>
<city>Granada</city>
<country country="ES">Spain</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<email>eu-fora@efsa.europa.eu</email>
</corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2022</year></pub-date><volume>20</volume><issue>Suppl 2</issue><issue-id pub-id-type="doi">10.1002/efs2.v20.s2</issue-id><issue-title content-type="special-issue-title">EU&#x02010;FORA Series 5</issue-title><elocation-id>e200915</elocation-id><permissions><!--&#x000a9; European Food Safety Authority--><copyright-statement content-type="article-copyright">&#x000a9; 2022 Wiley&#x02010;VCH Verlag GmbH &#x00026; Co. KgaA on behalf of the European Food Safety Authority.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyndlicense">https://creativecommons.org/licenses/by-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">http://creativecommons.org/licenses/by-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:EFS2-20-e200915.pdf"/><abstract><title>Abstract</title><p>This work explores three areas of relevance to the gut microbiome in the context of One Health; the incorporation of the microbiome in food safety risk assessment of xenobiotics; the identification and application of beneficial microbial components to various areas under One Health, and specifically, in the context of antimicrobial resistance. We conclude that, although challenging, focusing on the microbiota resilience, function and active components, are critical for advancing the incorporation of the gut microbiome in the risk assessment of xenobiotics. Moreover, research technologies, such as toxicomicrobiomics, culturomics and genomics, especially in combination, have revealed that the human microbiota may be a promising source of beneficial taxa or other components, with the potential to metabolise and biodegrade xenobiotics. These may have possible applications in several health areas, including in animals or plants for detoxification or in the environment for bioremediation. This approach would be of particular interest for antimicrobials, with the potential to ameliorate antimicrobial resistance development. Finally, we propose that the concept of resistance to xenobiotics in the context of the gut microbiome may deserve further investigation in the pursuit of holistically elucidating their involvement in the balance between health and disease.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="efs2e200915-kwd-0001">One Health</kwd><kwd id="efs2e200915-kwd-0002">gut microbiome</kwd><kwd id="efs2e200915-kwd-0003">xenobiotics</kwd><kwd id="efs2e200915-kwd-0004">microbiota&#x02010;disrupting chemicals</kwd><kwd id="efs2e200915-kwd-0005">next&#x02010;generation risk assessment</kwd><kwd id="efs2e200915-kwd-0006">antimicrobial resistance</kwd><kwd id="efs2e200915-kwd-0007">next&#x02010;generation probiotics</kwd></kwd-group><counts><fig-count count="3"/><table-count count="0"/><page-count count="20"/><word-count count="9668"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2022</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.2 mode:remove_FC converted:14.12.2022</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="efs2e200915-cit-1001">
<bold>Suggested citation:</bold>
<string-name>
<surname>Ampatzoglou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gruszecka&#x02010;Kosowska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aguilera&#x02010;G&#x000f3;mez</surname>
<given-names>M</given-names>
</string-name>, <year>2022</year>. <article-title>Microbiota analysis for risk assessment of xenobiotics: Toxicomicrobiomics, incorporating the gut microbiome in the risk assessment of xenobiotics and identifying beneficial components for One Health</article-title>. <source>EFSA supporting publication</source> 2022;<volume>20</volume>(<issue>S2</issue>):e200915, 20 pp. <pub-id pub-id-type="doi">10.2903/j.efsa.2022.e200915</pub-id>
</mixed-citation>
</p><fn-group id="efs2e200915-ntgp-0001"><fn id="efs2e200915-note-0004"><p>
<bold>Declarations of interest</bold> If you wish to access the declaration of interests of any expert contributing to an EFSA scientific assessment, please contact <email>interestmanagement@efsa.europa.eu</email>.
</p></fn><fn id="efs2e200915-note-0005"><p>
<bold>Acknowledgements</bold> This report is funded by EFSA as part of the EU&#x02010;FORA programme. The authors wish to thank the following members of the BIO190 Group (University of Granada), for their support; Alfonso Torres&#x02010;S&#x000e1;nchez; Ana L&#x000f3;pez&#x02010;Moreno; Klara Cerk; Pilar Ortiz; &#x000c1;ngel Ruiz&#x02010;Moreno; Mar&#x000ed;a Alejandra Moreno&#x02010;Rodr&#x000ed;guez; Alicia Ruiz&#x02010;Rodr&#x000ed;guez; and Mercedes Monteoliva&#x02010;S&#x000e1;nchez.
</p></fn><fn id="efs2e200915-note-0007"><p>
Approved: 31 August 2022
</p></fn></fn-group></notes></front><body id="efs2e200915-body-0001"><sec id="efs2e200915-sec-0001"><label>1</label><title>Introduction</title><sec id="efs2e200915-sec-0002"><label>1.1</label><title>Microbiome and One Health</title><p>The human microbiome, a characteristic microbial community occupying a complex, but reasonably well&#x02010;defined habitat with distinct physio&#x02010;chemical properties, encompasses the microorganisms involved (microbiota), as well as their structural and molecular elements (e.g. nucleic acids), metabolites and surrounding environmental conditions (Berg et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0012" ref-type="bibr">2020</xref>). One Health (OH) is the holistic methodology of transdisciplinary cooperation to improve human, animal, plant and environmental health simultaneously, and its adoption is continuously expanding (CDC,&#x02009;<xref rid="efs2e200915-bib-0014" ref-type="bibr">2020</xref>; Bronzwaer et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0013" ref-type="bibr">2021</xref>). Due to their functionalities and physiological potential and considering their known associations with a range of diseases, microbiomes are key elements in the OH framework (CNBBSV,&#x02009;<xref rid="efs2e200915-bib-0019" ref-type="bibr">2019</xref>; Merten et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0048" ref-type="bibr">2020</xref>). Their significance is partly due to pathogenic and commensal microbial transfer between humans, animals and the environment, and the human microbiome stands out with regard to its interactions with environmental and dietary chemicals that affect human health outcomes (Trinh et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0080" ref-type="bibr">2018</xref>). Of particular interest are the contact and mutual influence between the human gut microbiome (GM) and exogenous toxic chemicals, xenobiotics, focusing on their fate, metabolism and toxicity (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>; Abdelsalam et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0001" ref-type="bibr">2020</xref>).</p></sec><sec id="efs2e200915-sec-0003"><label>1.2</label><title>Microbiota&#x02010;disrupting chemicals and the gut microbiome</title><p>Among xenobiotics, endocrine&#x02010;disrupting chemicals (EDCs) are especially important and they have been associated with metabolic disorders, such as obesity, as well as with changes in the GM (G&#x000e1;lvez&#x02010;Ontiveros et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0027" ref-type="bibr">2020</xref>; Aguilera et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0003" ref-type="bibr">2021</xref>). Recently the concept of microbiota&#x02010;disrupting chemicals (MDCs) has been proposed, which comprise EDCs and other xenobiotics with potential to alter the gut microbiota's composition and metabolism (Aguilera et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0002" ref-type="bibr">2020</xref>) via dietary exposure, e.g. bisphenols, parabens (And&#x000fa;jar et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0005" ref-type="bibr">2019</xref>; Monteagudo et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0050" ref-type="bibr">2021</xref>; Robles&#x02010;Aguilera et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0063" ref-type="bibr">2021</xref>).</p><p>The interactions between MDCs and the GM are complex. This is partly because multiple general mechanisms are involved, including; direct effects of the MDC on the microbiome; altered epithelial&#x02010;barrier functions (affecting uptake or excretion of MDCs); direct chemical transformations of MDCs; secondary transformation of host&#x02010;generated metabolites (e.g. deconjugation by &#x003b2;&#x02010;glucuronidases); and altered expression of host&#x02010;tissue metabolic enzymes and pathways (e.g. in the liver via microbial signalling molecules) (Ulluwishewa et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0081" ref-type="bibr">2011</xref>; Patterson and Turnbaugh,&#x02009;<xref rid="efs2e200915-bib-0057" ref-type="bibr">2014</xref>; Peterson and Artis,&#x02009;<xref rid="efs2e200915-bib-0059" ref-type="bibr">2014</xref>; Kelly et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0033" ref-type="bibr">2015</xref>; Selwyn et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0069" ref-type="bibr">2015</xref>, <xref rid="efs2e200915-bib-0070" ref-type="bibr">2016</xref>; Claus et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0017" ref-type="bibr">2016</xref>; Spanogiannopoulos et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0076" ref-type="bibr">2016</xref>; NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>). Although these interactions can decrease MDC exposure and toxicity effects, they can also increase them. For example, several bacterial phyla in the human GM can produce azoreductases, which have been shown to reduce azo dyes that are common in foods into mutagenic and carcinogenic aromatic amines (Rafii et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0060" ref-type="bibr">1990</xref>; Xu et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0087" ref-type="bibr">2007</xref>). Overall, the role of these complex interactions in modifying human susceptibility to MDCs is beginning to be elucidated.</p></sec><sec id="efs2e200915-sec-0004"><label>1.3</label><title>Risk assessment of xenobiotics and the gut microbiome</title><p>Risk assessment (RA) is the science&#x02010;based component of the food safety risk analysis framework, alongside risk management and risk communication. RA comprising; hazard identification; hazard characterisation; exposure assessment; and risk characterisation (CAC,&#x02009;<xref rid="efs2e200915-bib-0018" ref-type="bibr">1999</xref>; European Commission, 2002). Traditionally, xenobiotic RA relies on data from animal experiments, human trials and/or human observational/epidemiological studies. Importantly, the extrapolation of this data across species or studied populations is not without challenge, partially due to GM variability (e.g. in homogeneous populations, such as healthy adults) and variation (e.g. between species or life stages) and the complexity of MDC/GM interactions (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>). Thus, the need for the incorporation of the GM in food safety RA of xenobiotics is well&#x02010;justified (Merten et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0048" ref-type="bibr">2020</xref>) and by extension to MDCs.</p></sec><sec id="efs2e200915-sec-0005"><label>1.4</label><title>Seeking beneficial taxa/components in the gut microbiome</title><p>Another area of relevance to the GM in the context of OH is the identification of beneficial taxa and derived components (e.g. enzymes and biocompounds) in the GM and their potential application. In this context, toxicomicrobiomics, which study the aforementioned microbiome&#x02010;xenobiotic/MDC interactions, along with culturomics, which aim to cultivate components of the human GM through the use of optimised selective and/or enrichment culture conditions coupled with metagenomic taxa identification, can shed light on the microbiome's capacity to metabolise xenobiotics (Aziz,&#x02009;<xref rid="efs2e200915-bib-0009" ref-type="bibr">2018</xref>; Lagier et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0035" ref-type="bibr">2018</xref>; CNBBSV,&#x02009;<xref rid="efs2e200915-bib-0019" ref-type="bibr">2019</xref>; Abdelsalam et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0001" ref-type="bibr">2020</xref>; L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0041" ref-type="bibr">2022</xref>) and by extension MDCs. Thus, these approaches can help identify GM components with beneficial effects under OH, for example detoxification activity (L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0042" ref-type="bibr">2021b</xref>) or next&#x02010;generation probiotics (NGPs) (L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0040" ref-type="bibr">2021a</xref>).</p></sec><sec id="efs2e200915-sec-0006"><label>1.5</label><title>Antimicrobial resistance and the gut microbiome</title><p>A third area of relevance is antimicrobial resistance (AMR). Undoubtedly, AMR is an important OH issue, with the major contributor being the misuse of antibiotics (WHO,&#x02009;<xref rid="efs2e200915-bib-0085" ref-type="bibr">2015</xref>, <xref rid="efs2e200915-bib-0086" ref-type="bibr">2021</xref>; O'Neill,&#x02009;<xref rid="efs2e200915-bib-0052" ref-type="bibr">2016</xref>). Moreover, the GM has previously been considered as a reservoir for antibiotic resistance genes (Gibson et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0028" ref-type="bibr">2015</xref>; Anthony et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0006" ref-type="bibr">2021</xref>). Moreover, non&#x02010;antibiotic antimicrobials, including MDCs triclosan and parabens, commonly used as preservatives in foods, food contact materials (FCMs) and personal care products (Soni et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0072" ref-type="bibr">2001</xref>, <xref rid="efs2e200915-bib-0074" ref-type="bibr">2002</xref>, <xref rid="efs2e200915-bib-0073" ref-type="bibr">2005</xref>; CIR,&#x02009;<xref rid="efs2e200915-bib-0020" ref-type="bibr">2008</xref>; Halden et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0031" ref-type="bibr">2017</xref>), may also contribute to AMR (SCCS,&#x02009;<xref rid="efs2e200915-bib-0067" ref-type="bibr">2010</xref>). This is because some resistance mechanisms are common to both biocidal MDCs and antibiotics, for example, the former may; exert selective stress leading to the expression of bacterial resistance mechanisms and their dissemination; and/or maintain mobile genetic elements carrying genes involved in antibiotic cross&#x02010;resistance (SCENIHR,&#x02009;<xref rid="efs2e200915-bib-0068" ref-type="bibr">2009</xref>). Therefore, detoxification potential from specific GM taxa become of particular interest in the context of such antimicrobials.</p></sec></sec><sec id="efs2e200915-sec-0007"><label>2</label><title>Work programme</title><sec id="efs2e200915-sec-0008"><label>2.1</label><title>Aims</title><p>This work builds upon a previous EU&#x02010;FORA project (Cerk and Aguilera&#x02010;Gomez,&#x02009;<xref rid="efs2e200915-bib-0015" ref-type="bibr">2022</xref>) and aims to explore three areas of relevance to the microbiome in the context of OH. Firstly, the incorporation of the GM in RA of xenobiotics was explored. Secondly, the potential application of beneficial GM taxa (or their bioactive compounds), identified via toxicomicrobiomics and culturomics approaches was considered. Finally, a specific aspect of this application was further investigated in the context of AMR, and xenobiotic resistance was also considered.</p></sec><sec id="efs2e200915-sec-0009"><label>2.2</label><title>Additional activities</title><p>Additional activities and training opportunities were identified during this EU&#x02010;FORA fellowship project, based on the fellow's background and professional interests. These are listed in Appendix&#x02009;<xref rid="efs2e200915-sec-1001" ref-type="sec">A</xref>.</p></sec><sec id="efs2e200915-sec-0010"><label>2.3</label><title>Outputs</title><p>The three focal areas of this work and their links to each&#x02010;other, OH and the GM are summarised in Figure&#x02009;<xref rid="efs2e200915-fig-0001" ref-type="fig">1</xref>. The first area, i.e. the incorporation of the GM in RA of xenobiotics, relates primarily to human health. However, depending on the output of the RA and the antimicrobial or not nature of the xenobiotic, the other two areas, i.e. the application of beneficial GM taxa/compounds generally or specifically in the context of AMR, could be highly relevant to holistic xenobiotic risk management.</p><fig position="float" fig-type="Figure" id="efs2e200915-fig-0001"><label>Figure 1</label><caption><p>Three interlinked areas of relevance to the human gut microbiome (GM) in the context of One Health (OH); incorporation of the GM in food safety risk assessment of xenobiotics; identification and application of beneficial GM taxa and components (e.g., enzymes and bioactive compounds) to various areas under OH, and; specifically, in the context of antimicrobial resistance. EDC: endocrine disrupting chemicals, MDC(s): microbiota disrupting chemicals (Ampatzoglou et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0004" ref-type="bibr">2022</xref>)</p></caption><graphic xlink:href="EFS2-20-e200915-g003" position="anchor" id="jats-graphic-1"/></fig><p>The following sections present the outputs for each of these three areas. These have been previously published in a scientific journal (Ampatzoglou et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0004" ref-type="bibr">2022</xref>) and presented at scientific conferences, during the fellowship programme. Further detail is available in Annex&#x02009;<xref rid="efs2e200915-sec-1002" ref-type="sec">A</xref>.</p><sec id="efs2e200915-sec-0011"><label>2.3.1</label><title>Moving towards the gut microbiome's incorporation in risk assessment of xenobiotics</title><sec id="efs2e200915-sec-0012"><label>2.3.1.1</label><title>The need &#x02013; current challenges to address</title><p>GM variation and variability adds layers of complexity to the already intricate interactions between MDCs and health. The observed differences in the composition, gene content and function of the GM has been attributed to multiple factors including age (Yatsunenko et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0088" ref-type="bibr">2012</xref>), antibiotic use (Dethlefsen and Relman,&#x02009;<xref rid="efs2e200915-bib-0022" ref-type="bibr">2011</xref>), diet (Yatsunenko et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0088" ref-type="bibr">2012</xref>), disease state (Mar et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0044" ref-type="bibr">2016</xref>), environmental exposures (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>), exercise (O'Sullivan et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0053" ref-type="bibr">2015</xref>), genetics (Goodrich et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0029" ref-type="bibr">2014</xref>), geography (Yatsunenko et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0088" ref-type="bibr">2012</xref>), pregnancy status (Koren et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0034" ref-type="bibr">2012</xref>), sex (Markle et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0045" ref-type="bibr">2013</xref>), socioeconomic status (Levin et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0037" ref-type="bibr">2016</xref>) and surgical interventions (Tremaroli et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0079" ref-type="bibr">2015</xref>). Moreover, these factors may only explain a small fraction of the total GM variation (Falony et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0024" ref-type="bibr">2016</xref>; CNBBSV,&#x02009;<xref rid="efs2e200915-bib-0019" ref-type="bibr">2019</xref>). Importantly, due to this variability, observations of microbiome&#x02010;influenced toxicities in a studied population might have little relevance to other populations with substantially different GM composition and function (Rodricks et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0064" ref-type="bibr">2019</xref>).</p><p>In addition, there is considerable variation between the GMs of humans and animals, due to anatomical, physiological, functional, immunological and compositional differences. Some of these have been partially overcome via the use of &#x02018;humanised&#x02019; animals in toxicological studies (Sonnenburg and B&#x000e4;ckhed,&#x02009;<xref rid="efs2e200915-bib-0075" ref-type="bibr">2016</xref>). Nevertheless, extrapolation from such studies to humans still carries considerable uncertainty (Rodricks et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0064" ref-type="bibr">2019</xref>) and, along with the intraspecies variability, necessitates the use of uncertainty/safety factors, frequently reaching two orders of magnitude (Dorne and Renwick,&#x02009;<xref rid="efs2e200915-bib-0023" ref-type="bibr">2005</xref>; Benford et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0011" ref-type="bibr">2018</xref>). Based on these factors, traditional RAs may overestimate or underestimate the risk associated with exposure to an MDC, partially because they do not account for its interactions with the microbiome (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>; Merten et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0048" ref-type="bibr">2020</xref>). Consequent risk management decisions may place considerable pressure on the industry. For example, EFSA's recent proposal to considerably reduce the tolerable daily intake for bisphenol A (BPA) (EFSA, <xref rid="efs2e200915-bib-1018" ref-type="bibr">2021</xref>), may further increase the use of bisphenol analogues in FCMs, which may also trigger dysbiosis and obesogenic phenotypes (And&#x000fa;jar et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0005" ref-type="bibr">2019</xref>; Monteagudo et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0050" ref-type="bibr">2021</xref>).</p><p>Although the need is clear to incorporate the GM in the RA of xenobiotics, there are additional hurdles, i.e. the fundamental requirements to; establish causation and molecular mechanisms linking phenotypes, e.g. obesity, with microbiota profiles (Fischbach,&#x02009;<xref rid="efs2e200915-bib-0025" ref-type="bibr">2018</xref>); and define what constitutes a healthy GM, which still remains elusive (Merten et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0048" ref-type="bibr">2020</xref>). Considering that these tasks require significant resources, it might be a useful first step to establish principles on how to evaluate the potential of xenobiotics to alter the GM.</p></sec><sec id="efs2e200915-sec-0013"><label>2.3.1.2</label><title>Assessing the potential of xenobiotics to alter the gut microbiome</title><p>Interestingly, a three&#x02010;tier framework has recently been proposed by the Unilever Safety and Environmental Assurance Centre for assessing the potential of personal care formulations to perturb the skin and oral microbiomes (M&#x000e9;tris et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0049" ref-type="bibr">2021</xref>). The following sections briefly present this framework and suggest amendments which could make it suitable for application to the GM in the context of xenobiotic RA.</p><sec id="efs2e200915-sec-0014"><title>First tier &#x02013; xenobiotic cross&#x02010;reference</title><p>The first tier benchmarks new formulations against ones regarded as safe because of a long &#x02018;history of safe use&#x02019; (HoSU). However, this approach cannot apply directly to xenobiotics, for reasons such as their nature as contaminants or that they may not be intended to be ingested (e.g., if used in FCMs). Moreover, it is challenging to establish robust links between GM, cumulative exposure and resulting adverse effects (Gruszecka&#x02010;Kosowska et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0030" ref-type="bibr">2022</xref>; Ortiz et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0055" ref-type="bibr">2022</xref>). Nevertheless, evidence has been compiling in recent years on the impact of several contaminants and groups of xenobiotics, including pesticides, bisphenols, phthalates, metals, triclosan, parabens and polybrominated diphenyl ethers, on human and animal gut microbiomes (Aguilera et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0002" ref-type="bibr">2020</xref>). As it expands, this evidence could potentially serve as an early cross&#x02010;reference tier which would raise initial concerns, depending on the nature and chemical structure of a xenobiotic under RA.</p></sec><sec id="efs2e200915-sec-0015"><title>Second tier &#x02013; microbiome resilience</title><p>The second tier focuses on microbiome resilience. Other authors highlighted resilience, along with resistance to perturbation, as a key feature of healthy microbiomes, attributed to their rich and diverse metabolic pathways (Lloyd&#x02010;Price et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0039" ref-type="bibr">2016</xref>; McBain et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0047" ref-type="bibr">2019</xref>; Cheng et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0016" ref-type="bibr">2022</xref>). Importantly, this tier assesses risk in relative terms. Thus, it circumvents the need to define the healthy microbiome, since it is only concerned about the return to its baseline state, independently of whether healthy or desirable. Of course, the length of exposure of the microbiome to the potential perturbator would be a critical consideration. Overall, however, this tier could be a reasonable approach to screen MDCs based on the resilience of the GM under various experimental approaches, extending from &#x02018;humanised&#x02019; animals (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>) to <italic toggle="yes">ex&#x000a0;vivo</italic> and <italic toggle="yes">in&#x000a0;vitro</italic> models, such as simulator of the human intestinal microbial ecosystem (SHIME) (Van den Abbeele et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0083" ref-type="bibr">2012</xref>), minibioreactor arrays (Auchtung et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0008" ref-type="bibr">2015</xref>) and multi&#x02010;compartment microfluidic&#x02010;based gut&#x02010;on&#x02010;chip systems (De Gregorio et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0021" ref-type="bibr">2020</xref>; Signore et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0071" ref-type="bibr">2021</xref>).</p></sec><sec id="efs2e200915-sec-0016"><title>Third tier &#x02013; elucidating links between changes in the gut microbiome and health status</title><p>Finally, the third tier makes use of next&#x02010;generation sequencing microbiome data in relation to host health status. This requires further development, is the most challenging tier and is, certainly, relevant to the RA of xenobiotics in the context of the GM. M&#x000e9;tris et&#x000a0;al.&#x02009;(<xref rid="efs2e200915-bib-0049" ref-type="bibr">2021</xref>) highlighted the requirement to focus not only on the microbiome's composition (including both relative and absolute abundances), but more importantly on its function. This is not surprising, given that microbiome variability between relatively homogeneous groups of people (e.g. healthy individuals of same sex and similar age) is less prominent at the functional level (Tian et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0077" ref-type="bibr">2020</xref>) and that compositional variation, more generally, might not necessarily impart key functional differences due to functional redundancy (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>). Regarding research methodology, metatranscriptomics, is an established approach to focus on the functional taxa in the microbiome. More recent methodologies, however, have combined flow cytometry with omics technologies to characterise active microbial fractions in the GM, revealing a number of taxa underrepresented by traditional 16S rRNA metagenomics (Peris&#x02010;Bondia et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0058" ref-type="bibr">2011</xref>; Maurice et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0046" ref-type="bibr">2013</xref>). These approaches are likely to offer valuable insights in the extrapolation of this tier's approach to the GM, especially in the pursuit for key species or other types of biomarkers associated with host health or disease, which will be crucial for the incorporation of the GM in the RA of MDCs.</p></sec></sec></sec><sec id="efs2e200915-sec-0017"><label>2.3.2</label><title>Identifying beneficial gut microbiome taxa/components for application under One Health</title><p>Taxa culturing strategies, in the context of the interactional triangle between EDCs (obesogens)&#x02010;gut microbiota (dysbiosis vs eubiosis)&#x02010;human health (obesity vs leanness), are key in obtaining and selecting strains (associated with pro&#x02010;obesity and antiobesity phenotypes) with potential use as NGPs (L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0040" ref-type="bibr">2021a</xref>). The latter, unlike traditional probiotics, do not have a defined HoSU, and are thus subjected to more stringent regulatory requirements (O'Toole et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0054" ref-type="bibr">2017</xref>; Cerk and Aguilera&#x02010;Gomez,&#x02009;<xref rid="efs2e200915-bib-0015" ref-type="bibr">2022</xref>). Nevertheless, strains isolated from the human gut could more readily be used under OH, e.g. as probiotics for animals, plants and environmental protection and bioremediation.</p><p>Recent work has demonstrated that toxicomicrobiomics and culturomics are promising in exploring the potential of human GM taxa to metabolise obesogenic MDCs and selecting species able to tolerate or biodegrade BPA (L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0042" ref-type="bibr">2021b</xref>; L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0041" ref-type="bibr">2022</xref>). Moreover, whole&#x02010;genome sequence (WGS) analysis of a relevant <italic toggle="yes">Bacillus</italic> species derived from the human gut microbiota shed light on the encoded metabolic pathways and key enzymes involved in BPA breakdown (Figure&#x02009;<xref rid="efs2e200915-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="Figure" id="efs2e200915-fig-0002"><label>Figure 2</label><caption><p>Proposed biodegradation pathways of bis&#x02010;phenol A based on the whole&#x02010;genome sequence analysis of <italic toggle="yes">Bacillus</italic> species AM1: reaction steps, enzymes, EC number, protein ID, and specific genes loci (with permission from L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0042" ref-type="bibr">2021b</xref>)</p></caption><graphic xlink:href="EFS2-20-e200915-g001" position="anchor" id="jats-graphic-3"/></fig><p>Thus, similar approaches, involving toxicomicrobiomics, culturomics and genomics, could be used going forward to explore the human GM as a source of beneficial microbes (NGPs), enzymes and bioactive compounds linked to MDC detoxification or biodegradation, with various potential applications under OH (Figures&#x02009;<xref rid="efs2e200915-fig-0001" ref-type="fig">1</xref> and <xref rid="efs2e200915-fig-0003" ref-type="fig">3</xref>).</p><fig position="float" fig-type="Figure" id="efs2e200915-fig-0003"><label>Figure 3</label><caption><p>Next Generation Probiotics (NGPs), probiotics and biodegraders derived via culturing from the gut microbiota in the context of the triad micro&#x02010;biome (dysbiosis vs eubiosis) &#x02013; endocrine disrupting chemicals (EDCs)/xenobiotics/obesogens &#x02013; human health (obesity vs normal weight) and their envisaged application in three areas under One Health (presented to the International e&#x02010;Symposium on Probiotics, Prebiotics &#x00026; Gut Microbiome: Key Regulators for Human &#x00026; Animal Health, November 11, 2021, Ludhiana, India)</p></caption><graphic xlink:href="EFS2-20-e200915-g004" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="efs2e200915-sec-0018"><label>2.3.3</label><title>Gut microbiome and antimicrobial resistance under One Health</title><p>MDCs, such as triclosan and parabens, contribute to the AMR issue, primarily through resistance development against themselves (self&#x02010;resistance), but also potentially through development of cross&#x02010;resistance against antibiotics (Ribado et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0062" ref-type="bibr">2017</xref>). Although the evidence supporting cross&#x02010;resistance development in&#x000a0;situ is not conclusive (SCCS,&#x02009;<xref rid="efs2e200915-bib-0067" ref-type="bibr">2010</xref>), the potential contribution of MDCs to AMR and their mechanisms merit further data compilation (Valkova et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0082" ref-type="bibr">2002</xref>; Hughes et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0032" ref-type="bibr">2020</xref>; Rozman et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0065" ref-type="bibr">2021</xref>). Moreover, given that antimicrobial MDCs would likely have higher potential to alter and perturb microbiomes (compared to non&#x02010;antimicrobial xenobiotics), they have been proposed as candidate chemicals in investigations that would built our understanding around the xenobiotic&#x02010;microbiome interactions in the context of xenobiotic RA (NASEM,&#x02009;<xref rid="efs2e200915-bib-0051" ref-type="bibr">2018</xref>).</p><p>Nevertheless, even non&#x02010;antimicrobial xenobiotics may pose resistance development issues in the context of the GM, as exposure to them may apply a selective pressure in favour of microbial taxa with specific enzymatic arsenals and metabolic pathways. For example, L&#x000f3;pez&#x02010;Moreno et&#x000a0;al.&#x02009;(<xref rid="efs2e200915-bib-0041" ref-type="bibr">2022</xref>), associated BPA exposure and the obese phenotype in children to higher BPA biodegradation potential in their GM. Moreover, they reported that BPA&#x02010;resistant strains isolated from human gut microbiota exhibited xenobiotic biodegradation and antimicrobial effects linked to polyketide biosynthesis (Torres&#x02010;S&#x000e1;nchez et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0078" ref-type="bibr">2021</xref>). Therefore, in the presence of BPA, these strains may further modulate the composition and function of the human gut microbiota, potentially reducing GM diversity and inducing dysbiosis and adverse metabolic effects (Aguilera et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0002" ref-type="bibr">2020</xref>). The mechanisms, via which gut microbiome taxa may be affected by non&#x02010;antibacterial MDCs, potentially leading to dysbiosis, could include growth inhibition or promotion and metabolism modulation (Lindell et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0038" ref-type="bibr">2022</xref>). For example, several artificial sweeteners, spice extracts and food dyes have been shown to inhibit the growth of specific bacterial strains <italic toggle="yes">in&#x000a0;vivo</italic>, while certain natural xenobiotics and food additives appear to promote the growth of other strains under similar conditions, likely acting as nutrient sources (Pan et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0056" ref-type="bibr">2012</xref>; de Bello Gonz&#x000e1;lez et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0010" ref-type="bibr">2016</xref>; Lu et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0043" ref-type="bibr">2017</xref>; Wang et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0084" ref-type="bibr">2018</xref>; Ruiz&#x02010;Ojeda et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0066" ref-type="bibr">2019</xref>; Frame et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0026" ref-type="bibr">2020</xref>). Additionally, an alkaloid found naturally in coffee, trigonelline, has shown potential to alter the metabolism of a common human gut commensal in&#x000a0;vivo (Anwar et&#x000a0;al.,&#x02009;<xref rid="efs2e200915-bib-0007" ref-type="bibr">2018</xref>). Although limited, this evidence suggests that the potential for xenobiotic resistance development, in the context of the GM, may warrant further consideration and research, beyond antimicrobial resistance.</p><p>Overall, applying GM taxa and biocompounds able to metabolise antimicrobial MDCs to crosscutting areas under OH could potentially ameliorate AMR pressure (Figure&#x02009;<xref rid="efs2e200915-fig-0001" ref-type="fig">1</xref>).</p></sec></sec></sec><sec sec-type="conclusions" id="efs2e200915-sec-0019"><label>3</label><title>Conclusions</title><p>The explored three areas of relevance to the GM in the context of OH open new avenues of research; the incorporation of the GM in RA of xenobiotics; the identification and application of beneficial GM components to various areas under OH, and specifically, in the context of AMR. This work took a first step with this combined approach and reached the following conclusions:</p><p>
<list list-type="bullet" id="efs2e200915-list-1501"><list-item><p>Focusing on the GM's resilience circumvents some of the challenges. Moreover, looking at function, rather than composition, and exploring the active components of the GM can help establish biomarkers of health and disease, which is necessary for the incorporation of the GM in the RA of xenobiotics.</p></list-item><list-item><p>The human GM may be a promising source of beneficial microbes (i.e. probiotics and NGPs), enzymes and bioactive compounds, with the potential to metabolise xenobiotics. These can be explored with toxicomicrobiomics and culturomics and may have potential applications in various areas under OH, e.g., as probiotics in animals or plants for xenobiotic detoxification or as xenobiotic biodegraders in environmental protection and bioremediation.</p></list-item><list-item><p>This approach would be of particular interest for antimicrobials (such as triclosan or parabens), because applying relevant components isolated from the human GM to similar areas under OH could help ameliorate the risk of AMR development.</p></list-item><list-item><p>Finally, the concept of resistance in the context of the GM could theoretically be extended from antimicrobials to xenobiotics, and the notion of xenobiotic resistance may warrant further consideration.</p></list-item></list>
</p></sec><sec><def-list list-content="abbreviations" id="efs2e200915-lp-0001"><title>Abbreviations</title><def-item><term id="efs2e200915-li-0001">AMR</term><def id="efs2e200915-li-0002"><p>antimicrobial RESISTANCE</p></def></def-item><def-item><term id="efs2e200915-li-0003">BPA</term><def id="efs2e200915-li-0004"><p>Bisphenol A</p></def></def-item><def-item><term id="efs2e200915-li-0005">CAC</term><def id="efs2e200915-li-0006"><p>Codex Alimentarius Commission</p></def></def-item><def-item><term id="efs2e200915-li-0007">CDC</term><def id="efs2e200915-li-0008"><p>Centers for Disease Control and Prevention</p></def></def-item><def-item><term id="efs2e200915-li-0009">CIR</term><def id="efs2e200915-li-0010"><p>Cosmetic Ingredient Review Expert Panel</p></def></def-item><def-item><term id="efs2e200915-li-0011">CNBBSV</term><def id="efs2e200915-li-0012"><p>Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita</p></def></def-item><def-item><term id="efs2e200915-li-0013">EDCs</term><def id="efs2e200915-li-0014"><p>endocrine&#x02010;disrupting chemicals</p></def></def-item><def-item><term id="efs2e200915-li-0015">FCMs</term><def id="efs2e200915-li-0016"><p>food contact materials</p></def></def-item><def-item><term id="efs2e200915-li-0017">GM</term><def id="efs2e200915-li-0018"><p>(human) gut microbiome</p></def></def-item><def-item><term id="efs2e200915-li-0019">HoSU</term><def id="efs2e200915-li-0020"><p>History of Safe Use</p></def></def-item><def-item><term id="efs2e200915-li-0021">INYTA</term><def id="efs2e200915-li-0022"><p>&#x0201c;Jos&#x000e9; Mataix Verd&#x000fa;&#x0201d; Institute of Nutrition and Food Technology</p></def></def-item><def-item><term id="efs2e200915-li-0023">MDCs</term><def id="efs2e200915-li-0024"><p>microbiota&#x02010;disrupting chemicals</p></def></def-item><def-item><term id="efs2e200915-li-0025">NASEM</term><def id="efs2e200915-li-0026"><p>National Academies of Sciences, Engineering, and Medicine</p></def></def-item><def-item><term id="efs2e200915-li-0027">OH</term><def id="efs2e200915-li-0028"><p>One Health</p></def></def-item><def-item><term id="efs2e200915-li-0029">RA</term><def id="efs2e200915-li-0030"><p>risk assessment</p></def></def-item><def-item><term id="efs2e200915-li-0031">SCCS</term><def id="efs2e200915-li-0032"><p>Scientific Committee on Consumer Safety</p></def></def-item><def-item><term id="efs2e200915-li-0033">SCENIHR</term><def id="efs2e200915-li-0034"><p>Scientific Committee on Emerging and Newly Identified Health Risks</p></def></def-item><def-item><term id="efs2e200915-li-0035">SHIME</term><def id="efs2e200915-li-0036"><p>Simulator of the Human Intestinal Microbial Ecosystem</p></def></def-item><def-item><term id="efs2e200915-li-0037">UGR</term><def id="efs2e200915-li-0038"><p>University of Granada</p></def></def-item><def-item><term id="efs2e200915-li-0039">WGS</term><def id="efs2e200915-li-0040"><p>whole&#x02010;genome sequence</p></def></def-item><def-item><term id="efs2e200915-li-0041">WHO</term><def id="efs2e200915-li-0042"><p>World Health Organization</p></def></def-item></def-list></sec><sec id="efs2e200915-sec-1001"><title>Appendix A &#x02013; Additional activities undertaken by A. Ampatzoglou</title><p>The fellow joined the Biology and Biotechnology Group (BIO190, Halophilic Microorganisms and Environmental Bioremediation Research Group) at the hosting site (UGR), successfully applied to the UK Science Council for the Chartered Scientist (CSci) award, via his professional body, the Institute of Food Science and Technology (IFST) and attended the EU&#x02010;FORA training modules and additional training opportunities. Salient examples are listed below.
<list list-type="bullet" id="efs2e200915-list-0001"><list-item id="efs2e200915-li-0043"><p>EU&#x02010;FORA training modules by EFSA, the Austrian Agency for Health and Food Safety (AGES), the German Federal Institute for Risk Assessment (BfR) &#x00026; the Hellenic Food Authority (EFET) on the following topics:
<list list-type="simple" id="efs2e200915-list-0002"><list-item id="efs2e200915-li-0044"><label>&#x01d52;</label><p>Data collection and reporting, 22&#x02013;25 August 2022, online.</p></list-item><list-item id="efs2e200915-li-0045"><label>&#x01d52;</label><p>Emerging Risks, Nanomaterials, Omics in Risk Assessment &#x00026; Risk Ranking, 6&#x02013;10 Jun 2022, Athens, Greece.</p></list-item><list-item id="efs2e200915-li-0046"><label>&#x01d52;</label><p>Risk Perception, Risk Communication, Crisis Response &#x00026; Media Training, 21&#x02013;25 March 2022, Berlin, Germany and online.</p></list-item><list-item id="efs2e200915-li-0047"><label>&#x01d52;</label><p>Genetically Modified Organisms, Animal Health, Animal Welfare, Plant Health, Pesticides, Nutritional &#x00026; Environmental Risk Assessment, 22&#x02013;26 November 2021, Vienna, Austria and online.</p></list-item><list-item id="efs2e200915-li-0048"><label>&#x01d52;</label><p>EU Food Safety System &#x00026; Legislation &#x00026; a comprehensive overview of Microbiological &#x00026; Chemical Risk Assessment (induction training), 30 August&#x02013;17 September 2021, Parma, Italy and online.</p></list-item></list>
</p></list-item><list-item id="efs2e200915-li-0049"><p>US Food and Drug Administration (FDA) and Alliance to Stop Foodborne Illness, Collaborating on Culture in the New Era of Smarter Food Safety, Food Safety Culture webinar series, including:
<list list-type="simple" id="efs2e200915-list-0003"><list-item id="efs2e200915-li-0050"><label>&#x01d52;</label><p>Building a coalition of food safety culture champions in your organisation, 18 May 2022</p></list-item><list-item id="efs2e200915-li-0051"><label>&#x01d52;</label><p>Making Leaders Risk Aware and Push to Reduce Risk, 16 February 2022.</p></list-item><list-item id="efs2e200915-li-0052"><label>&#x01d52;</label><p>Kick Off Meeting, 4 November 2021.</p></list-item></list>
</p></list-item><list-item id="efs2e200915-li-0053"><p>BfR and Federal Office of Consumer Protection and Food Safety (BVL), Super(?)foods and Supplements &#x02013; Risky or Healthy? 30 June&#x02013;1 July 2022, online conference.</p></list-item><list-item id="efs2e200915-li-0054"><p>EFSA, European Centre for Disease Prevention and Control (ECDC), European Chemicals Agency (ECHA), European Environment Agency (EEA), European Medicines Agency (EMA) &#x00026; Joint Research Centre (JRC), ONE &#x02013; Health, Environment, Society &#x02013; Conference 2022, 21&#x02013;24 June 2022, Brussels and online conference.</p></list-item><list-item id="efs2e200915-li-0055"><p>Microbiome Virtual International Forum online webinar series, including:
<list list-type="simple" id="efs2e200915-list-0004"><list-item id="efs2e200915-li-0056"><label>&#x01d52;</label><p>Toward the development of defined microbial therapeutics, 16 June 2022.</p></list-item><list-item id="efs2e200915-li-0057"><label>&#x01d52;</label><p>Topic models for interpretable multidomain microbiome data, 9 February 2022.</p></list-item></list>
</p></list-item><list-item id="efs2e200915-li-0058"><p>US FDA Grand Rounds online webinar, including:
<list list-type="simple" id="efs2e200915-list-0005"><list-item id="efs2e200915-li-0059"><label>&#x01d52;</label><p>One Health at FDA: From Concept to Application, 14 June 2022.</p></list-item><list-item id="efs2e200915-li-0060"><label>&#x01d52;</label><p>MinION Sequencing of Foodborne Pathogens, 14 April 2022.</p></list-item></list>
</p></list-item><list-item id="efs2e200915-li-0061"><p>FoodSafety4EU EU Green Week Partner Event, How can we communicate food safety in the context of sustainable food systems? 1 June 2022, online event.</p></list-item><list-item id="efs2e200915-li-0062"><p>The institute of Food Science and Technology (IFST), Spring Conference (SC22) &#x02013; Minding the Gap; Communication, Skills and Technologies, 4&#x02013;6 May 2022, online conference.</p></list-item><list-item id="efs2e200915-li-0063"><p>The Frontiers Forum, The CRISPR health revolution, 31 March 2022, online webinar.</p></list-item><list-item id="efs2e200915-li-0064"><p>EU&#x02010;FORA training visit to the Spanish Agency for Food Safety &#x00026; Nutrition (AESAN), covering Risk Assessment &#x00026; the AESAN Scientific Committee, Risk Communication &#x00026; Risk Management of Biological &#x00026; Chemical Hazards, Nutritional Safety, Food Official Control &#x00026; Alerts, 23&#x02013;24 February 2022, Madrid.</p></list-item><list-item id="efs2e200915-li-0065"><p>EU&#x02010;FORA training visit to the Spanish National Centre for Food (CNA), covering Food Contact Materials, Food Processing Contaminants, Veterinary Drug Residues, Biotechnology, Microbiology &#x00026; Antimicrobial Resistance, 25 February 2022, Majadahonda, Spain.</p></list-item><list-item id="efs2e200915-li-0066"><p>University of Granada, Machine Learning and Big Data for Bioinformatics, 7 February&#x02013;1 April 2022, massive open online course (MOOC).</p></list-item><list-item id="efs2e200915-li-0067"><p>European Institute of Innovation and Technology (EIT) Food, The Human Microbiome, 24 January&#x02013;11 February 2022, MOOC.</p></list-item><list-item id="efs2e200915-li-0068"><p>EIT Food, The Future of Food Conference 2021, 30 November&#x02013;1 December 2021, virtual event.</p></list-item><list-item id="efs2e200915-li-0069"><p>Introduction to BioCyc for New Life Sciences Graduate Students and Post Docs, covering; Introduction to BioCyc; Smart tables and Comparative Analysis, and; Transcriptomics and Metabolomics Data Analysis, 3, 10 and 17 November 2021, online webinar series.</p></list-item><list-item id="efs2e200915-li-0070"><p>Workshop OBEMIRISK&#x02010;Knowledge platform for assessing the risk of Bisphenols on gut microbiota and its role in obesogenic phenotype: looking for biomarkers, 14&#x02013;15 October 2021, Granada.</p></list-item></list>
</p></sec><sec id="efs2e200915-sec-1002"><title>Annex A &#x02013; Scientific output dissemination of EU&#x02010;FORA fellowship project</title><p>The following outputs of this EU&#x02010;FORA fellowship project have been published in scientific journals or communicated in scientific conferences.</p><sec id="efs2e200915-sec-0022"><title>A.1. Scientific papers</title><p>Torres&#x02010;S&#x000e1;nchez A, L&#x000f3;pez&#x02010;Moreno A, Moreno A, Ortiz P, <bold>Ampatzoglou A</bold>, <bold>Gruszecka&#x02010;Kosowska A</bold>, Ruiz&#x02010;Rodr&#x000ed;guez A, Monteoliva&#x02010;S&#x000e1;nchez M, <bold>Aguilera M</bold>, 2022. Microbiome taxa and metabolite profiles altered in endocrine disorders or by xenobiotics and the counteraction with Next Generation Probiotics, International Journal of Molecular Sciences, review submitted for publication.</p><p>
<bold>Gruszecka&#x02010;Kosowska A</bold>, <bold>Ampatzoglou A</bold>, <bold>Aguilera M</bold>, 2022. Integration of Omics approaches enhances the impact of scientific research in environmental applications. International Journal of Environmental Research and Public Health, 19(14), 8,758. <ext-link xlink:href="https://doi.org/10.3390/ijerph19148758" ext-link-type="uri">doi: 10.3390/ijerph19148758</ext-link>.</p><p>
<bold>Ampatzoglou A</bold>, <bold>Gruszecka&#x02010;Kosowska A</bold>, Torres&#x02010;S&#x000e1;nchez A, L&#x000f3;pez&#x02010;Moreno A, Cerk K, Ortiz P, Monteoliva&#x02010;S&#x000e1;nchez M, <bold>Aguilera M</bold>, 2022. Incorporating the gut microbiome in the risk assessment of xenobiotics &#x00026; identifying beneficial components for One Health. Frontiers in Microbiology, 13, 872,583. doi: <ext-link xlink:href="https://doi.org/10.3389/fmicb.2022.872583" ext-link-type="uri">10.3389/fmicb.2022.872583</ext-link>.</p><p>Ortiz P, Torres&#x02010;S&#x000e1;nchez A, L&#x000f3;pez&#x02010;Moreno A, Cerk K, Ruiz&#x02010;Moreno &#x000c1;, Monteoliva&#x02010;S&#x000e1;nchez M, <bold>Ampatzoglou A</bold>, <bold>Aguilera M</bold>, <bold>Gruszecka&#x02010;Kosowska A</bold>, 2022. Impact of cumulative environmental &#x00026; dietary xenobiotics on human microbiota: risk assessment for one health. Journal of Xenobiotics, 12(1), 56&#x02013;63. doi: <ext-link xlink:href="https://doi.org/10.3390/jox12010006" ext-link-type="uri">10.3390/jox12010006</ext-link>.</p></sec><sec id="efs2e200915-sec-0023"><title>A.2. Poster communications at scientific conferences</title><p>Moreno A, <underline underline-style="single">Ortiz P</underline>, L&#x000f3;pez&#x02010;Moreno A, Torres&#x02010;S&#x000e1;nchez A, <bold>Ampatzoglou A</bold>, <bold>Gruszecka&#x02010;Kosowska A</bold>, Ruiz&#x02010;Rodr&#x000ed;guez A, Monteoliva&#x02010;S&#x000e1;nchez M, <bold>Aguilera M</bold>, 2022. Representaci&#x000f3;n de taxones microbianos cultivables inducidos por exposici&#x000f3;n a xenobi&#x000f3;ticos en microbiota de ni&#x000f1;os. XIX Taxon, Reuni&#x000f3;n del Grupo de Taxonom&#x000ed;a, Filogenia y Biodiversidad, October 13&#x02013;15, 2022, Mallorca, Spain (abstract accepted).<underline underline-style="single">
<bold>Ampatzoglou A</bold>
</underline>, <bold>Gruszecka&#x02010;Kosowska A</bold>, L&#x000f3;pez&#x02010;Moreno A, Cerk K, Torres&#x02010;S&#x000e1;nchez A, Ruiz&#x02010;Moreno A, Ortiz P, Monteoliva M, <bold>Aguilera M</bold>, 2021. Toxicomicrobiomics for elucidating the capacity of the gut microbiota taxa to metabolise xenobiotics and identifying beneficial microbes within the One Health approach. International e&#x02010;Symposium on Probiotics, Prebiotics &#x00026; Gut Microbiome: Key Regulators for Human &#x00026; Animal Health, November 11, 2021, Ludhiana, India (<bold>Best poster award received&#x02010;presented by A. Ampatzoglou</bold>).</p><p>
<inline-graphic xlink:href="EFS2-20-e200915-g002.jpg" xlink:title="image"/>
</p></sec><sec id="efs2e200915-sec-0024"><title>A.3. Oral communication at scientific conference</title><p>
<underline underline-style="single">
<bold>Ampatzoglou A</bold>
</underline>, <bold>Gruszecka&#x02010;Kosowska A</bold>, Torres&#x02010;S&#x000e1;nchez A, L&#x000f3;pez&#x02010;Moreno A, Cerk K, Ortiz P, Monteoliva&#x02010;S&#x000e1;nchez M, <bold>Aguilera M</bold>, 2022. Exploring the incorporation of gut microbiome omics data in next&#x02010;generation risk assessment of xenobiotics in foods. Next Generation Challenges in Food Microbiology, FoodMicro 2022, August 28&#x02013;31, 2022, Athens, Greece (abstract accepted).</p></sec></sec></body><back><ref-list content-type="cited-references" id="efs2e200915-bibl-0001"><title>References</title><ref id="efs2e200915-bib-0001"><mixed-citation publication-type="journal" id="efs2e200915-cit-0001">
<string-name>
<surname>Abdelsalam</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Ramadan</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>ElRakaiby</surname>
<given-names>MT</given-names>
</string-name> and <string-name>
<surname>Aziz</surname>
<given-names>RK</given-names>
</string-name>, <year>2020</year>. <article-title>Toxicomicrobiomics: the human microbiome vs. pharmaceutical, dietary, and environmental xenobiotics</article-title>. <source>Frontiers in Pharmacology</source>, <volume>11</volume>, <fpage>390</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00390</pub-id>
<pub-id pub-id-type="pmid">32372951</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0002"><mixed-citation publication-type="journal" id="efs2e200915-cit-0002">
<string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>G&#x000e1;lvez&#x02010;Ontiveros</surname>
<given-names>Y</given-names>
</string-name> and <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <year>2020</year>. <article-title>Endobolome, a new concept for determining the influence of microbiota disrupting chemicals (MDC) in relation to specific endocrine pathogenesis</article-title>. <source>Frontiers in Microbiology</source>, <volume>11</volume>, <elocation-id>578007</elocation-id>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.578007</pub-id>
<pub-id pub-id-type="pmid">33329442</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0003"><mixed-citation publication-type="journal" id="efs2e200915-cit-0003">
<string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lamas</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Van Pamel</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bhide</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Houdeau</surname>
<given-names>E</given-names>
</string-name> and <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <year>2021</year>. <article-title>Editorial: risk of dietary hazardous substances and impact on human microbiota: possible role in several dysbiosis phenotypes</article-title>. <source>Frontiers in Microbiology</source>, <volume>12</volume>, <elocation-id>669480</elocation-id>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.669480</pub-id>
<pub-id pub-id-type="pmid">33968005</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0004"><mixed-citation publication-type="journal" id="efs2e200915-cit-0004">
<string-name>
<surname>Ampatzoglou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gruszecka&#x02010;Kosowska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Torres&#x02010;S&#x000e1;nchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>L&#x000f3;pez&#x02010;Moreno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cerk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ortiz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Monteoliva&#x02010;S&#x000e1;nchez</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <year>2022</year>. <article-title>Incorporating the gut microbiome in the risk assessment of xenobiotics &#x00026; identifying beneficial components for One Health</article-title>. <source>Frontiers in Microbiology</source>, <volume>13</volume>, <elocation-id>872583</elocation-id>. <pub-id pub-id-type="doi">10.3389/fmicb.2022.872583</pub-id>
<pub-id pub-id-type="pmid">35602014</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0005"><mixed-citation publication-type="journal" id="efs2e200915-cit-0005">
<string-name>
<surname>And&#x000fa;jar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>G&#x000e1;lvez&#x02010;Ontiveros</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zafra&#x02010;G&#x000f3;mez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rodrigo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>&#x000c1;lvarez&#x02010;Cubero</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Monteagudo</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <year>2019</year>. <article-title>Bisphenol A analogues in food and their hormonal and obesogenic effects: a review</article-title>. <source>Nutrients</source>, <volume>11</volume>, <fpage>2136</fpage>. <pub-id pub-id-type="doi">10.3390/nu11092136</pub-id>
<pub-id pub-id-type="pmid">31500194</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0006"><mixed-citation publication-type="journal" id="efs2e200915-cit-0006">
<string-name>
<surname>Anthony</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Burnham</surname>
<given-names>C&#x02010;AD</given-names>
</string-name>, <string-name>
<surname>Dantas</surname>
<given-names>G</given-names>
</string-name> and <string-name>
<surname>Kwon</surname>
<given-names>JH</given-names>
</string-name>, <year>2021</year>. <article-title>The gut microbiome as a reservoir for antimicrobial resistance</article-title>. <source>The Journal of Infectious Diseases</source>, <volume>223</volume>, <fpage>S209</fpage>&#x02013;<lpage>S213</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiaa497</pub-id>
<pub-id pub-id-type="pmid">33326581</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0007"><mixed-citation publication-type="journal" id="efs2e200915-cit-0007">
<string-name>
<surname>Anwar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bhandari</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Panda</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Dubey</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>W</given-names>
</string-name> and <string-name>
<surname>Ahmad</surname>
<given-names>S</given-names>
</string-name>, <year>2018</year>. <article-title>Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk</article-title>. <source>Journal of Pharmaceutical and Biomedical Analysis</source>, <volume>159</volume>, <fpage>100</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2018.06.027</pub-id>
<pub-id pub-id-type="pmid">29980011</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0008"><mixed-citation publication-type="journal" id="efs2e200915-cit-0008">
<string-name>
<surname>Auchtung</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>CD</given-names>
</string-name> and <string-name>
<surname>Britton</surname>
<given-names>RA</given-names>
</string-name>, <year>2015</year>. <article-title>Cultivation of stable, reproducible microbial communities from different fecal donors using minibioreactor arrays (MBRAs)</article-title>. <source>Microbiome</source>, <volume>3</volume>, <fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-015-0106-5</pub-id>
<pub-id pub-id-type="pmid">26419531</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0009"><mixed-citation publication-type="journal" id="efs2e200915-cit-0009">
<string-name>
<surname>Aziz</surname>
<given-names>RK</given-names>
</string-name>, <year>2018</year>. <article-title>Toxicomicrobiomics: narrowing the gap between environmental and medicinal toxicogenomics</article-title>. <source>OMICS: A Journal of Integrative Biology</source>, <volume>22</volume>, <fpage>788</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2018.0183</pub-id>
<pub-id pub-id-type="pmid">30571608</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0010"><mixed-citation publication-type="journal" id="efs2e200915-cit-0010">
<string-name>
<surname>de Bello Gonz&#x000e1;lez</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Zuidema</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bor</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Smidt</surname>
<given-names>H</given-names>
</string-name> and <string-name>
<surname>van MWJ</surname>
<given-names>P</given-names>
</string-name>, <year>2016</year>. <article-title>Study of the aminoglycoside subsistence phenotype of bacteria residing in the gut of humans and zoo animals</article-title>. <source>Frontiers in Microbiology</source>, <volume>6</volume>. <pub-id pub-id-type="doi">10.3389/fmicb.2015.01550</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0011"><mixed-citation publication-type="journal" id="efs2e200915-cit-0011">
<string-name>
<surname>Benford</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Halldorsson</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jeger</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Knutsen</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>More</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Naegeli</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Noteborn</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ockleford</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ricci</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rychen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Schlatter</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Silano</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Turck</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Younes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Craig</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Von Goetz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Koutsoumanis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mortensen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ossendorp</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Martino</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Merten</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mosbach&#x02010;Schulz</surname>
<given-names>O</given-names>
</string-name> and <string-name>
<surname>Hardy</surname>
<given-names>A</given-names>
</string-name>, <year>2018</year>. <article-title>Guidance on uncertainty analysis in scientific assessments</article-title>. <source>EFSA Journal</source> 2018, <volume>16</volume>(<issue>1</issue>), <fpage>5123</fpage>, 39 pp. <pub-id pub-id-type="doi">10.2903/j.efsa.2018.5123</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0012"><mixed-citation publication-type="journal" id="efs2e200915-cit-0012">
<string-name>
<surname>Berg</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rybakova</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Cernava</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Verg&#x000e8;s</surname>
<given-names>M&#x02010;CC</given-names>
</string-name>, <string-name>
<surname>Charles</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Cocolin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Eversole</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Corral</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Kazou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kinkel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lange</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Loy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Macklin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Maguin</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mauchline</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>McClure</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mitter</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sarand</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Smidt</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Schelkle</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Roume</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kiran</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Selvin</surname>
<given-names>J</given-names>
</string-name>, Souza RSC de, <string-name>
<surname>van Overbeek</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sessitsch</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schloter</surname>
<given-names>M</given-names>
</string-name>, <year>2020</year>. <article-title>Microbiome definition re&#x02010;visited: old concepts and new challenges</article-title>. <source>Microbiome</source>, <volume>8</volume>, <fpage>103</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40168-020-00875-0</pub-id>.<pub-id pub-id-type="pmid">32605663</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0013"><mixed-citation publication-type="journal" id="efs2e200915-cit-0013">
<string-name>
<surname>Bronzwaer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Geervliet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hugas</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Url</surname>
<given-names>B</given-names>
</string-name>, <year>2021</year>. <article-title>EFSA's expertise supports One Health policy needs</article-title>. <source>EFSA Journal</source> 2021, <volume>19</volume>(<issue>5</issue>), <elocation-id>e190501</elocation-id>, 4 pp. <pub-id pub-id-type="doi">10.2903/j.efsa.2021.e190501</pub-id>
<pub-id pub-id-type="pmid">34012492</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0020"><mixed-citation publication-type="journal" id="efs2e200915-cit-0020">
<collab collab-type="authors">CIR (Cosmetic Ingredient Review Expert Panel)</collab>
, <year>2008</year>. <article-title>Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products</article-title>. <source>International Journal of Toxicology</source>, <volume>27</volume>, <fpage>1</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1080/10915810802548359</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0014"><mixed-citation publication-type="miscellaneous" id="efs2e200915-cit-0014">
<collab collab-type="authors">CDC (Centers for Disease Control and Prevention)</collab>
, <year>2020</year>. <article-title>One Health basics</article-title>. Available online: <ext-link xlink:href="https://www.cdc.gov/onehealth/basics/index.html" ext-link-type="uri">https://www.cdc.gov/onehealth/basics/index.html</ext-link> [Accessed: 19 January 2022]</mixed-citation></ref><ref id="efs2e200915-bib-0015"><mixed-citation publication-type="journal" id="efs2e200915-cit-0015">
<string-name>
<surname>Cerk</surname>
<given-names>K</given-names>
</string-name> and <string-name>
<surname>Aguilera&#x02010;Gomez</surname>
<given-names>M</given-names>
</string-name>, <year>2022</year>. <article-title>Microbiota analysis for risk assessment: evaluation of hazardous dietary substances and its potential role on the gut microbiome variability and dysbiosis</article-title>. <source>EFSA Journal</source> 2022;<volume>20</volume>(<issue>S1</issue>):<elocation-id>e200404</elocation-id>, 16 pp. <pub-id pub-id-type="doi">10.2903/j.efsa.2022.e200404</pub-id>
<pub-id pub-id-type="pmid">35634548</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0016"><mixed-citation publication-type="journal" id="efs2e200915-cit-0016">
<string-name>
<surname>Cheng</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Bu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>G</given-names>
</string-name> and <string-name>
<surname>Ning</surname>
<given-names>K</given-names>
</string-name>, <year>2022</year>. <article-title>Microbiome resilience and health implications for people in half&#x02010;year travel</article-title>. <source>Frontiers in Immunology</source>, <volume>13</volume>, <elocation-id>848994</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.848994</pub-id>
<pub-id pub-id-type="pmid">35281043</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0018"><mixed-citation publication-type="book" id="efs2e200915-cit-0018">
<collab collab-type="authors">CAC (Codex Alimentarius Commission)</collab>
, <year>1999</year>. <source>Principles and Guidelines for the Conduct of Microbiological Risk Assessment CAC/GL 30&#x02010;1999</source> The Secretariat of the Joint Food and Agriculture Organisation (FAO)/World Health Organisation (WHO) Food Standards Programme, FAO, Rome, Italy.</mixed-citation></ref><ref id="efs2e200915-bib-0017"><mixed-citation publication-type="journal" id="efs2e200915-cit-0017">
<string-name>
<surname>Claus</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Guillou</surname>
<given-names>H</given-names>
</string-name> and <string-name>
<surname>Ellero&#x02010;Simatos</surname>
<given-names>S</given-names>
</string-name>, <year>2016</year>. <article-title>The gut microbiota: a major player in the toxicity of environmental pollutants?</article-title>
<source>NPJ Biofilms and Microbiomes</source>, <volume>2</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/npjbiofilms.2016.3</pub-id>
<pub-id pub-id-type="pmid">28649395</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0019"><mixed-citation publication-type="miscellaneous" id="efs2e200915-cit-0019">
<collab collab-type="authors">CNBBSV (Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita)</collab>
, <year>2019</year>. <article-title>Concept paper. Italian microbiome initiative for improved human health and agri&#x02010;food production. Presidenza del Consiglio dei Ministri Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita</article-title>.</mixed-citation></ref><ref id="efs2e200915-bib-0021"><mixed-citation publication-type="journal" id="efs2e200915-cit-0021">
<string-name>
<surname>De Gregorio</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Telesco</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Corrado</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Rosiello</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Urciuolo</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Netti</surname>
<given-names>PA</given-names>
</string-name> and <string-name>
<surname>Imparato</surname>
<given-names>G</given-names>
</string-name>, <year>2020</year>. <article-title>Intestine&#x02010;liver axis on&#x02010;chip reveals the intestinal protective role on hepatic damage by emulating ethanol first&#x02010;pass metabolism</article-title>. <source>Frontiers in Bioengineering and Biotechnology</source>, <volume>8</volume>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.00163</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0022"><mixed-citation publication-type="journal" id="efs2e200915-cit-0022">
<string-name>
<surname>Dethlefsen</surname>
<given-names>L</given-names>
</string-name> and <string-name>
<surname>Relman</surname>
<given-names>DA</given-names>
</string-name>, <year>2011</year>. <article-title>Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation</article-title>. <source>CIR</source>, <volume>108</volume>, <fpage>4554</fpage>&#x02013;<lpage>4561</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1000087107</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0023"><mixed-citation publication-type="journal" id="efs2e200915-cit-0023">
<string-name>
<surname>Dorne</surname>
<given-names>JLCM</given-names>
</string-name> and <string-name>
<surname>Renwick</surname>
<given-names>AG</given-names>
</string-name>, <year>2005</year>. <article-title>The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans</article-title>. <source>Toxicological Sciences</source>, <volume>86</volume>, <fpage>20</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfi160</pub-id>
<pub-id pub-id-type="pmid">15800035</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-1018"><mixed-citation publication-type="miscellaneous" id="efs2e200915-cit-1018">
<collab collab-type="authors">EFSA (European Food Safety Authority)</collab>
, <year>2021</year>. <article-title>Bisphenol A: EFSA draft opinion proposes lowering the tolerable&#x000a0;daily intake</article-title>. <ext-link xlink:href="https://www.efsa.europa.eu/en/news/bisphenol-efsa-draft-opinion-proposes-lowering-tolerable-daily-intake" ext-link-type="uri">https://www.efsa.europa.eu/en/news/bisphenol-efsa-draft-opinion-proposes-lowering-tolerable-daily-intake</ext-link> (accessed: 17/10/22).</mixed-citation></ref><ref id="efs2e200915-bib-0024"><mixed-citation publication-type="journal" id="efs2e200915-cit-0024">
<string-name>
<surname>Falony</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Joossens</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vieira&#x02010;Silva</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Darzi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Faust</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kurilshikov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bonder</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Valles&#x02010;Colomer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vandeputte</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tito</surname>
<given-names>RY</given-names>
</string-name>, <string-name>
<surname>Chaffron</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rymenans</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Verspecht</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sutter</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Lima&#x02010;Mendez</surname>
<given-names>G</given-names>
</string-name>, <string-name>D'<surname>hoe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jonckheere</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Homola</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tigchelaar</surname>
<given-names>EF</given-names>
</string-name>, <string-name>
<surname>Eeckhaudt</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Henckaerts</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhernakova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wijmenga</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Raes</surname>
<given-names>J</given-names>
</string-name>, <year>2016</year>. <article-title>Population&#x02010;level analysis of gut microbiome variation</article-title>. <source>Science</source>, <pub-id pub-id-type="doi">10.1126/science.aad3503</pub-id>, <volume>352</volume>, <fpage>560</fpage>, <lpage>564</lpage>.<pub-id pub-id-type="pmid">27126039</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0025"><mixed-citation publication-type="journal" id="efs2e200915-cit-0025">
<string-name>
<surname>Fischbach</surname>
<given-names>MA</given-names>
</string-name>, <year>2018</year>. <article-title>Microbiome: focus on causation and mechanism</article-title>. <source>Cell</source>, <volume>174</volume>, <fpage>785</fpage>&#x02013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.038</pub-id>
<pub-id pub-id-type="pmid">30096310</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0026"><mixed-citation publication-type="journal" id="efs2e200915-cit-0026">
<string-name>
<surname>Frame</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Costa</surname>
<given-names>E</given-names>
</string-name> and <string-name>
<surname>Jackson</surname>
<given-names>SA</given-names>
</string-name>, <year>2020</year>. <article-title>Current explorations of nutrition and the gut microbiome: a comprehensive evaluation of the review literature</article-title>. <source>Nutrition Reviews</source>, <volume>78</volume>, <fpage>798</fpage>&#x02013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuz106</pub-id>
<pub-id pub-id-type="pmid">32211860</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0027"><mixed-citation publication-type="journal" id="efs2e200915-cit-0027">
<string-name>
<surname>G&#x000e1;lvez&#x02010;Ontiveros</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>P&#x000e1;ez</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Monteagudo</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <year>2020</year>. <article-title>Endocrine disruptors in food: impact on gut microbiota and metabolic diseases</article-title>. <source>Nutrients</source>, <volume>12</volume>, <fpage>1158</fpage>. <pub-id pub-id-type="doi">10.3390/nu12041158</pub-id>
<pub-id pub-id-type="pmid">32326280</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0028"><mixed-citation publication-type="journal" id="efs2e200915-cit-0028">
<string-name>
<surname>Gibson</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Crofts</surname>
<given-names>TS</given-names>
</string-name> and <string-name>
<surname>Dantas</surname>
<given-names>G</given-names>
</string-name>, <year>2015</year>. <article-title>Antibiotics and the developing infant gut microbiota and resistome</article-title>. <source>Current Opinion in Microbiology</source>, <volume>27</volume>, <fpage>51</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2015.07.007</pub-id>
<pub-id pub-id-type="pmid">26241507</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0029"><mixed-citation publication-type="journal" id="efs2e200915-cit-0029">
<string-name>
<surname>Goodrich</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Waters</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Poole</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Sutter</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Koren</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Blekhman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Beaumont</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Van Treuren</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Spector</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>AG</given-names>
</string-name> and <string-name>
<surname>Ley</surname>
<given-names>RE</given-names>
</string-name>, <year>2014</year>. <article-title>Human genetics shape the gut microbiome</article-title>. <source>Cell</source>, <volume>159</volume>, <fpage>789</fpage>&#x02013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.053</pub-id>
<pub-id pub-id-type="pmid">25417156</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0030"><mixed-citation publication-type="journal" id="efs2e200915-cit-0030">
<string-name>
<surname>Gruszecka&#x02010;Kosowska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ampatzoglou</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <year>2022</year>. <article-title>Integration of omics approaches enhances the impact of scientific research in environmental applications</article-title>. <source>International Journal of Environmental Research and Public Health</source>, <volume>19</volume>, <fpage>8758</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19148758</pub-id>
<pub-id pub-id-type="pmid">35886610</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0031"><mixed-citation publication-type="journal" id="efs2e200915-cit-0031">
<string-name>
<surname>Halden</surname>
<given-names>RU</given-names>
</string-name>, <string-name>
<surname>Lindeman</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Aiello</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Andrews</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Arnold</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Fair</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fuoco</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Geer</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>PI</given-names>
</string-name>, <string-name>
<surname>Lohmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>McNeill</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sacks</surname>
<given-names>VP</given-names>
</string-name>, <string-name>
<surname>Schettler</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zoeller</surname>
<given-names>RT</given-names>
</string-name> and <string-name>
<surname>Blum</surname>
<given-names>A</given-names>
</string-name>, <year>2017</year>. <article-title>The florence statement on triclosan and triclocarban</article-title>. <source>Environmental Health Perspectives</source>, <volume>125</volume>, <elocation-id>064501</elocation-id>. <pub-id pub-id-type="doi">10.1289/EHP1788</pub-id>
<pub-id pub-id-type="pmid">28632490</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0032"><mixed-citation publication-type="journal" id="efs2e200915-cit-0032">
<string-name>
<surname>Hughes</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>W</given-names>
</string-name> and <string-name>
<surname>Johnson</surname>
<given-names>D</given-names>
</string-name>, <year>2020</year>. <article-title>The impact of DNA adenine methyltransferase knockout on the development of triclosan resistance and antibiotic cross&#x02010;resistance in <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>Access Microbiology</source>, <volume>3</volume>, <elocation-id>acmi000178</elocation-id>. <pub-id pub-id-type="doi">10.1099/acmi.0.000178</pub-id>
<pub-id pub-id-type="pmid">33997609</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0033"><mixed-citation publication-type="journal" id="efs2e200915-cit-0033">
<string-name>
<surname>Kelly</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cryan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dinan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>G</given-names>
</string-name> and <string-name>
<surname>Hyland</surname>
<given-names>N</given-names>
</string-name>, <year>2015</year>. <article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress&#x02010;related psychiatric disorders</article-title>. <source>Frontiers in Cellular Neuroscience</source>, <volume>9</volume>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00392</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0034"><mixed-citation publication-type="journal" id="efs2e200915-cit-0034">
<string-name>
<surname>Koren</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Goodrich</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Cullender</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Spor</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Laitinen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kling B&#x000e4;ckhed</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Werner</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Angenent</surname>
<given-names>LT</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>B&#x000e4;ckhed</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Isolauri</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Salminen</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Ley</surname>
<given-names>RE</given-names>
</string-name>, <year>2012</year>. <article-title>Host remodeling of the gut microbiome and metabolic changes during pregnancy</article-title>. <source>Cell</source>, <volume>150</volume>, <fpage>470</fpage>&#x02013;<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.07.008</pub-id>
<pub-id pub-id-type="pmid">22863002</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0035"><mixed-citation publication-type="journal" id="efs2e200915-cit-0035">
<string-name>
<surname>Lagier</surname>
<given-names>J&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Dubourg</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Million</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cadoret</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bilen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fenollar</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Levasseur</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rolain</surname>
<given-names>J&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Fournier</surname>
<given-names>P&#x02010;E</given-names>
</string-name> and <string-name>
<surname>Raoult</surname>
<given-names>D</given-names>
</string-name>, <year>2018</year>. <article-title>Culturing the human microbiota and culturomics</article-title>. <source>Nature Reviews Microbiology</source>, <volume>16</volume>, <fpage>540</fpage>&#x02013;<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-018-0041-0</pub-id>
<pub-id pub-id-type="pmid">29937540</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0036"><mixed-citation publication-type="journal" id="efs2e200915-cit-0036">
<string-name>
<surname>Lambr&#x000e9;</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Baviera</surname>
<given-names>JMB</given-names>
</string-name>, <string-name>
<surname>Bolognesi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chesson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cocconcelli</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Crebelli</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gott</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Grob</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lampi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mengelers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mortensen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rivi&#x000e8;re</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Silano</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Steffensen</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tlustos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vernis</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zorn</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Batke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bignami</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Corsini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>FitzGerald</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gundert&#x02010;Remy</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Halldorsson</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ntzani</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schroeder</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Scanziani</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ulbrich</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Waalkens&#x02010;Berendsen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Woelfle</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Al Harraq</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Baert</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Castoldi</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Carf&#x000ec;</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Croera</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Van Loveren</surname>
<given-names>H</given-names>
</string-name>, <year>2022</year>. <article-title>Draft scientific opinion of EFSA Panel&#x000a0;on Food Contact Materials, enzymes and processing aids (CEP), re&#x02010;evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs</article-title>. <source>EFSA Journal</source>.</mixed-citation></ref><ref id="efs2e200915-bib-0037"><mixed-citation publication-type="journal" id="efs2e200915-cit-0037">
<string-name>
<surname>Levin</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Sitarik</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Havstad</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Fujimura</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Wegienka</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cassidy&#x02010;Bushrow</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zoratti</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Lukacs</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Boushey</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Ownby</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>SV</given-names>
</string-name> and <string-name>
<surname>Johnson</surname>
<given-names>CC</given-names>
</string-name>, <year>2016</year>. <article-title>Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity</article-title>. <source>Scientific Reports</source>, <volume>6</volume>, <elocation-id>31775</elocation-id>. <pub-id pub-id-type="doi">10.1038/srep31775</pub-id>
<pub-id pub-id-type="pmid">27558272</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0038"><mixed-citation publication-type="journal" id="efs2e200915-cit-0038">
<string-name>
<surname>Lindell</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Zimmermann&#x02010;Kogadeeva</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Patil</surname>
<given-names>KR</given-names>
</string-name>, <year>2022</year>. <article-title>Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota</article-title>. <source>Nature Reviews Microbiology</source>, <volume>20</volume>, <fpage>431</fpage>&#x02013;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-022-00681-5</pub-id>
<pub-id pub-id-type="pmid">35102308</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0039"><mixed-citation publication-type="journal" id="efs2e200915-cit-0039">
<string-name>
<surname>Lloyd&#x02010;Price</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Abu&#x02010;Ali</surname>
<given-names>G</given-names>
</string-name> and <string-name>
<surname>Huttenhower</surname>
<given-names>C</given-names>
</string-name>, <year>2016</year>. <article-title>The healthy human microbiome</article-title>. <source>Genome Medicine</source>, <volume>8</volume>, <fpage>51</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-016-0307-y</pub-id>
<pub-id pub-id-type="pmid">27122046</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0040"><mixed-citation publication-type="journal" id="efs2e200915-cit-0040">
<string-name>
<surname>L&#x000f3;pez&#x02010;Moreno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Acu&#x000f1;a</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Torres&#x02010;S&#x000e1;nchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ruiz&#x02010;Moreno</surname>
<given-names>&#x000c1;</given-names>
</string-name>, <string-name>
<surname>Cerk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Su&#x000e1;rez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Monteoliva&#x02010;S&#x000e1;nchez</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <year>2021a</year>. <article-title>Next generation probiotics for neutralizing obesogenic effects: taxa culturing searching strategies</article-title>. <source>Nutrients</source>, <volume>13</volume>, <fpage>1617</fpage>. <pub-id pub-id-type="doi">10.3390/nu13051617</pub-id>
<pub-id pub-id-type="pmid">34065873</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0041"><mixed-citation publication-type="journal" id="efs2e200915-cit-0041">
<string-name>
<surname>L&#x000f3;pez&#x02010;Moreno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ruiz&#x02010;Moreno</surname>
<given-names>&#x000c1;</given-names>
</string-name>, <string-name>
<surname>Pardo&#x02010;Cacho</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cerk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Torres&#x02010;S&#x000e1;nchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ortiz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>&#x000da;beda</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <year>2022</year>. <article-title>Culturing and molecular approaches for identifying microbiota taxa impacting children's obesogenic phenotypes related to xenobiotic dietary exposure</article-title>. <source>Nutrients</source>, <volume>14</volume>, <fpage>241</fpage>. <pub-id pub-id-type="doi">10.3390/nu14020241</pub-id>
<pub-id pub-id-type="pmid">35057422</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0042"><mixed-citation publication-type="journal" id="efs2e200915-cit-0042">
<string-name>
<surname>L&#x000f3;pez&#x02010;Moreno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Torres&#x02010;S&#x000e1;nchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Acu&#x000f1;a</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Su&#x000e1;rez</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <year>2021b</year>. <article-title>Representative <italic toggle="yes">Bacillus</italic> sp. AM1 from gut microbiota harbor versatile molecular pathways for Bisphenol A biodegradation</article-title>. <source>International Journal of Molecular Sciences</source>, <volume>22</volume>, <fpage>4952</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22094952</pub-id>
<pub-id pub-id-type="pmid">34066922</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0043"><mixed-citation publication-type="journal" id="efs2e200915-cit-0043">
<string-name>
<surname>Lu</surname>
<given-names>Q&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Summanen</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>R&#x02010;P</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Henning</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Heber</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Finegold</surname>
<given-names>SM</given-names>
</string-name> and <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <year>2017</year>. <article-title>Prebiotic potential and chemical composition of seven culinary spice extracts</article-title>. <source>Journal of Food Science</source>, <volume>82</volume>, <fpage>1807</fpage>&#x02013;<lpage>1813</lpage>. <pub-id pub-id-type="doi">10.1111/1750-3841.13792</pub-id>
<pub-id pub-id-type="pmid">28678344</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0044"><mixed-citation publication-type="journal" id="efs2e200915-cit-0044">
<string-name>
<surname>Mar</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>LaMere</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Levan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nazareth</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mahadevan</surname>
<given-names>U</given-names>
</string-name> and <string-name>
<surname>Lynch</surname>
<given-names>SV</given-names>
</string-name>, <year>2016</year>. <article-title>Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients</article-title>. <source>mBio</source>, <volume>7</volume>. <pub-id pub-id-type="doi">10.1128/mBio.01072-16</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0045"><mixed-citation publication-type="journal" id="efs2e200915-cit-0045">
<string-name>
<surname>Markle</surname>
<given-names>JGM</given-names>
</string-name>, <string-name>
<surname>Frank</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Mortin&#x02010;Toth</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Feazel</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Rolle&#x02010;Kampczyk</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>von Bergen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McCoy</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Macpherson</surname>
<given-names>AJ</given-names>
</string-name> and <string-name>
<surname>Danska</surname>
<given-names>JS</given-names>
</string-name>, <year>2013</year>. <article-title>Sex differences in the gut microbiome drive hormone&#x02010;dependent regulation of autoimmunity</article-title>. <source>Science</source>, <volume>339</volume>, <fpage>1084</fpage>&#x02013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1126/science.1233521</pub-id>
<pub-id pub-id-type="pmid">23328391</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0046"><mixed-citation publication-type="journal" id="efs2e200915-cit-0046">
<string-name>
<surname>Maurice</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Haiser</surname>
<given-names>HJ</given-names>
</string-name> and <string-name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</string-name>, <year>2013</year>. <article-title>Xenobiotics shape the physiology and gene expression of the active human gut microbiome</article-title>. <source>Cell</source>, <volume>152</volume>, <fpage>39</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.10.052</pub-id>
<pub-id pub-id-type="pmid">23332745</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0047"><mixed-citation publication-type="journal" id="efs2e200915-cit-0047">
<string-name>
<surname>McBain</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>O'Neill</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Amezquita</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Faust</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tett</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Segata</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Swann</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hoptroff</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dasgupta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chapple</surname>
<given-names>IL</given-names>
</string-name>, <string-name>
<surname>Wade</surname>
<given-names>WG</given-names>
</string-name> and <string-name>
<surname>Fernandez&#x02010;Piquer</surname>
<given-names>J</given-names>
</string-name>, <year>2019</year>. <article-title>Consumer safety considerations of skin and oral microbiome perturbation</article-title>. <source>Clinical Microbiology Reviews</source>, <volume>32</volume>, <elocation-id>e00051&#x02010;19</elocation-id>. <pub-id pub-id-type="doi">10.1128/CMR.00051-19</pub-id>
<pub-id pub-id-type="pmid">31366612</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0048"><mixed-citation publication-type="journal" id="efs2e200915-cit-0048">
<string-name>
<surname>Merten</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schoonjans</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Di Gioia</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pel&#x000e1;ez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sanz</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Maurici</surname>
<given-names>D</given-names>
</string-name> and <string-name>
<surname>Robinson</surname>
<given-names>T</given-names>
</string-name>, <year>2020</year>. <article-title>Editorial: exploring the need to include microbiomes into EFSA's scientific assessments</article-title>. <source>EFSA Journal</source> 2020;<volume>18</volume>(<issue>6</issue>):<elocation-id>e18061</elocation-id>, 7 pp. <pub-id pub-id-type="doi">10.2903/j.efsa.2020.e18061</pub-id>
<pub-id pub-id-type="pmid">32874347</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0049"><mixed-citation publication-type="journal" id="efs2e200915-cit-0049">
<string-name>
<surname>M&#x000e9;tris</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Barrett</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Klamert</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Fernandez&#x02010;Piquer</surname>
<given-names>J</given-names>
</string-name>, <year>2021</year>. <article-title>A tiered approach to risk assess microbiome perturbations induced by application of beauty and personal care products</article-title>. <source>Microbial Risk Analysis</source>, <volume>20</volume>, <elocation-id>100188</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.mran.2021.100188</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0050"><mixed-citation publication-type="journal" id="efs2e200915-cit-0050">
<string-name>
<surname>Monteagudo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Robles&#x02010;Aguilera</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Salcedo&#x02010;Bellido</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>G&#x000e1;lvez&#x02010;Ontiveros</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Samaniego&#x02010;S&#x000e1;nchez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zafra&#x02010;G&#x000f3;mez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Burgos</surname>
<given-names>MAM</given-names>
</string-name> and <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <year>2021</year>. <article-title>Dietary exposure to parabens and body mass index in an adolescent Spanish population</article-title>. <source>Environmental Research</source>, <volume>201</volume>, <elocation-id>111548</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.envres.2021.111548</pub-id>
<pub-id pub-id-type="pmid">34166657</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0051"><mixed-citation publication-type="book" id="efs2e200915-cit-0051">
<collab collab-type="authors">NASEM (National Academies of Sciences, Engineering, and Medicine)</collab>
, <year>2018</year>. <source>Environmental Chemicals, the Human Microbiome, and Health Risk: A Research Strategy</source>. <publisher-name>The National Academies Press</publisher-name>, <publisher-loc>Washington, DC</publisher-loc>. <pub-id pub-id-type="doi">10.17226/24960</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0052"><mixed-citation publication-type="book" id="efs2e200915-cit-0052">
<string-name>
<surname>O'Neill</surname>
<given-names>J</given-names>
</string-name>, <year>2016</year>. <source>Tackling Drug&#x02010;Resistant Infections Globally: Final Report and Recommendations</source>. <publisher-name>Government of the United Kingdom</publisher-name>, <publisher-loc>London, UK</publisher-loc>.</mixed-citation></ref><ref id="efs2e200915-bib-0053"><mixed-citation publication-type="journal" id="efs2e200915-cit-0053">
<string-name>
<surname>O'Sullivan</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Cronin</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>EF</given-names>
</string-name>, <string-name>
<surname>Molloy</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Cotter</surname>
<given-names>PD</given-names>
</string-name>, <year>2015</year>. <article-title>Exercise and the microbiota</article-title>. <source>Gut Microbes</source>, <volume>6</volume>, <fpage>131</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2015.1011875</pub-id>
<pub-id pub-id-type="pmid">25800089</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0054"><mixed-citation publication-type="journal" id="efs2e200915-cit-0054">
<string-name>
<surname>O'Toole</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Marchesi</surname>
<given-names>JR</given-names>
</string-name> and <string-name>
<surname>Hill</surname>
<given-names>C</given-names>
</string-name>, <year>2017</year>. <article-title>Next&#x02010;generation probiotics: the spectrum from probiotics to live biotherapeutics</article-title>. <source>Nature Microbiology</source>, <volume>2</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.57</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0055"><mixed-citation publication-type="journal" id="efs2e200915-cit-0055">
<string-name>
<surname>Ortiz</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Torres&#x02010;S&#x000e1;nchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>L&#x000f3;pez&#x02010;Moreno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cerk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ruiz&#x02010;Moreno</surname>
<given-names>&#x000c1;</given-names>
</string-name>, <string-name>
<surname>Monteoliva&#x02010;S&#x000e1;nchez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ampatzoglou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Gruszecka&#x02010;Kosowska</surname>
<given-names>A</given-names>
</string-name>, <year>2022</year>. <article-title>Impact of cumulative environmental and dietary xenobiotics on human microbiota: risk assessment for One Health</article-title>. <source>Journal of Xenobiotics</source>, <volume>12</volume>, <fpage>56</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.3390/jox12010006</pub-id>
<pub-id pub-id-type="pmid">35323221</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0056"><mixed-citation publication-type="journal" id="efs2e200915-cit-0056">
<string-name>
<surname>Pan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>G&#x02010;X</given-names>
</string-name>, <string-name>
<surname>Cerniglia</surname>
<given-names>CE</given-names>
</string-name> and <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>, <year>2012</year>. <article-title>Evaluation of impact of exposure of Sudan azo dyes and their metabolites on human intestinal bacteria</article-title>. <source>Anaerobe</source>, <volume>18</volume>, <fpage>445</fpage>&#x02013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2012.05.002</pub-id>
<pub-id pub-id-type="pmid">22634331</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0057"><mixed-citation publication-type="journal" id="efs2e200915-cit-0057">
<string-name>
<surname>Patterson</surname>
<given-names>AD</given-names>
</string-name> and <string-name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</string-name>, <year>2014</year>. <article-title>Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology</article-title>. <source>Cell Metabolism</source>, <volume>20</volume>, <fpage>761</fpage>&#x02013;<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.07.002</pub-id>
<pub-id pub-id-type="pmid">25156450</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0058"><mixed-citation publication-type="journal" id="efs2e200915-cit-0058">
<string-name>
<surname>Peris&#x02010;Bondia</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Latorre</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Artacho</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moya</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>D'Auria</surname>
<given-names>G</given-names>
</string-name>, <year>2011</year>. <article-title>The active human gut microbiota differs from the total microbiota</article-title>. <source>PLoS One</source>, <volume>6</volume>, <elocation-id>e22448</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022448</pub-id>
<pub-id pub-id-type="pmid">21829462</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0059"><mixed-citation publication-type="journal" id="efs2e200915-cit-0059">
<string-name>
<surname>Peterson</surname>
<given-names>LW</given-names>
</string-name> and <string-name>
<surname>Artis</surname>
<given-names>D</given-names>
</string-name>, <year>2014</year>. <article-title>Intestinal epithelial cells: regulators of barrier function and immune homeostasis</article-title>. <source>Nature Reviews Immunology</source>, <volume>14</volume>, <fpage>141</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1038/nri3608</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0060"><mixed-citation publication-type="journal" id="efs2e200915-cit-0060">
<string-name>
<surname>Rafii</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Franklin</surname>
<given-names>W</given-names>
</string-name> and <string-name>
<surname>Cerniglia</surname>
<given-names>CE</given-names>
</string-name>, <year>1990</year>. <article-title>Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora</article-title>. <source>Applied and Environmental Microbiology</source>, <volume>56</volume>, <fpage>2146</fpage>&#x02013;<lpage>2151</lpage>. <pub-id pub-id-type="doi">10.1128/aem.56.7.2146-2151.1990</pub-id>
<pub-id pub-id-type="pmid">2202258</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0061"><mixed-citation publication-type="miscellaneous" id="efs2e200915-cit-0061">
<collab collab-type="authors">European Commission</collab>
, <article-title>Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety, 2002. Official Journal of the European Communities&#x02014;legislation series</article-title>.</mixed-citation></ref><ref id="efs2e200915-bib-0062"><mixed-citation publication-type="journal" id="efs2e200915-cit-0062">
<string-name>
<surname>Ribado</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Ley</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Haggerty</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Tkachenko</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bhatt</surname>
<given-names>AS</given-names>
</string-name> and <string-name>
<surname>Parsonnet</surname>
<given-names>J</given-names>
</string-name>, <year>2017</year>. <article-title>Household triclosan and triclocarban effects on the infant and maternal microbiome</article-title>. <source>EMBO Molecular Medicine</source>, <volume>9</volume>, <fpage>1732</fpage>&#x02013;<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201707882</pub-id>
<pub-id pub-id-type="pmid">29030459</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0063"><mixed-citation publication-type="journal" id="efs2e200915-cit-0063">
<string-name>
<surname>Robles&#x02010;Aguilera</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>G&#x000e1;lvez&#x02010;Ontiveros</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Rodrigo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Salcedo&#x02010;Bellido</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zafra&#x02010;G&#x000f3;mez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Monteagudo</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Rivas</surname>
<given-names>A</given-names>
</string-name>, <year>2021</year>. <article-title>Factors associated with exposure to dietary bisphenols in adolescents</article-title>. <source>Nutrients</source>, <volume>13</volume>, <fpage>1553</fpage>. <pub-id pub-id-type="doi">10.3390/nu13051553</pub-id>
<pub-id pub-id-type="pmid">34062990</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0064"><mixed-citation publication-type="journal" id="efs2e200915-cit-0064">
<string-name>
<surname>Rodricks</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mantus</surname>
<given-names>E</given-names>
</string-name> and <string-name>
<surname>Shubat</surname>
<given-names>P</given-names>
</string-name>, <year>2019</year>. <article-title>Do interactions between environmental chemicals and the human microbiome need to be considered in risk assessments?</article-title>
<source>Risk Analysis</source>, <volume>39</volume>, <fpage>2353</fpage>&#x02013;<lpage>2358</lpage>. <pub-id pub-id-type="doi">10.1111/risa.13316</pub-id>
<pub-id pub-id-type="pmid">31070803</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0065"><mixed-citation publication-type="journal" id="efs2e200915-cit-0065">
<string-name>
<surname>Rozman</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Pu&#x00161;nik</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kmetec</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Duh</surname>
<given-names>D</given-names>
</string-name> and <string-name>
<surname>&#x00160;ostar Turk</surname>
<given-names>S</given-names>
</string-name>, <year>2021</year>. <article-title>Reduced susceptibility and increased resistance of bacteria against disinfectants: a systematic review</article-title>. <source>Microorganisms</source>, <volume>9</volume>, <fpage>2550</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms9122550</pub-id>
<pub-id pub-id-type="pmid">34946151</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0066"><mixed-citation publication-type="journal" id="efs2e200915-cit-0066">
<string-name>
<surname>Ruiz&#x02010;Ojeda</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Plaza&#x02010;D&#x000ed;az</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>S&#x000e1;ez&#x02010;Lara</surname>
<given-names>MJ</given-names>
</string-name> and <string-name>
<surname>Gil</surname>
<given-names>A</given-names>
</string-name>, <year>2019</year>. <article-title>Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials</article-title>. <source>Advances in Nutrition</source>, <volume>10</volume>, <fpage>S31</fpage>&#x02013;<lpage>S48</lpage>. <pub-id pub-id-type="doi">10.1093/advances/nmy037</pub-id>
<pub-id pub-id-type="pmid">30721958</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0067"><mixed-citation publication-type="miscellaneous" id="efs2e200915-cit-0067">
<collab collab-type="authors">SCCS (Scientific Committee on Consumer Safety)</collab>
, <year>2010</year>. <article-title>Opinion on triclosan (antimicrobial resistance) (No. SCCP/1251/09). European Commission. Directorate&#x02010;General for Health and Consumers</article-title>.</mixed-citation></ref><ref id="efs2e200915-bib-0068"><mixed-citation publication-type="book" id="efs2e200915-cit-0068">
<collab collab-type="authors">SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks)</collab>
, <year>2009</year>. <source>Assessment of the Antibiotic Resistance Effects of Biocides</source>. <publisher-name>European Commission. Directorate&#x02010;General for Health and Consumers</publisher-name>, <publisher-loc>Brussels, Belgium</publisher-loc>.</mixed-citation></ref><ref id="efs2e200915-bib-0069"><mixed-citation publication-type="journal" id="efs2e200915-cit-0069">
<string-name>
<surname>Selwyn</surname>
<given-names>FP</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Bammler</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Prasad</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Vrana</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Klaassen</surname>
<given-names>C</given-names>
</string-name> and <string-name>
<surname>Cui</surname>
<given-names>JY</given-names>
</string-name>, <year>2015</year>. <article-title>Developmental regulation of drug&#x02010;processing genes in livers of germ&#x02010;free mice</article-title>. <source>Toxicological Sciences</source>, <volume>147</volume>, <fpage>84</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfv110</pub-id>
<pub-id pub-id-type="pmid">26032512</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0070"><mixed-citation publication-type="journal" id="efs2e200915-cit-0070">
<string-name>
<surname>Selwyn</surname>
<given-names>FP</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Klaassen</surname>
<given-names>CD</given-names>
</string-name> and <string-name>
<surname>Cui</surname>
<given-names>JY</given-names>
</string-name>, <year>2016</year>. <article-title>Regulation of hepatic drug&#x02010;metabolizing enzymes in germ&#x02010;free mice by conventionalization and probiotics</article-title>. <source>Drug Metabolism and Disposition</source>, <volume>44</volume>, <fpage>262</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.115.067504</pub-id>
<pub-id pub-id-type="pmid">26586378</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0071"><mixed-citation publication-type="journal" id="efs2e200915-cit-0071">
<string-name>
<surname>Signore</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>De Pascali</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Giampetruzzi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Siciliano</surname>
<given-names>PA</given-names>
</string-name> and <string-name>
<surname>Francioso</surname>
<given-names>L</given-names>
</string-name>, <year>2021</year>. <article-title>Gut&#x02010;on&#x02010;Chip microphysiological systems: latest advances in the integration of sensing strategies and adoption of mature detection mechanisms</article-title>. <source>Sensing and Bio&#x02010;Sensing Research</source>, <volume>33</volume>, <elocation-id>100443</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.sbsr.2021.100443</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0072"><mixed-citation publication-type="journal" id="efs2e200915-cit-0072">
<string-name>
<surname>Soni</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Burdock</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>SL</given-names>
</string-name> and <string-name>
<surname>Greenberg</surname>
<given-names>NA</given-names>
</string-name>, <year>2001</year>. <article-title>Safety assessment of propyl paraben: a review of the published literature</article-title>. <source>Food and Chemical Toxicology</source>, <volume>39</volume>, <fpage>513</fpage>&#x02013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/s0278-6915(00)00162-9</pub-id>
<pub-id pub-id-type="pmid">11346481</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0073"><mixed-citation publication-type="journal" id="efs2e200915-cit-0073">
<string-name>
<surname>Soni</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Carabin</surname>
<given-names>IG</given-names>
</string-name> and <string-name>
<surname>Burdock</surname>
<given-names>GA</given-names>
</string-name>, <year>2005</year>. <article-title>Safety assessment of esters of p&#x02010;hydroxybenzoic acid (parabens)</article-title>. <source>Food and Chemical Toxicology</source>, <volume>43</volume>, <fpage>985</fpage>&#x02013;<lpage>1015</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2005.01.020</pub-id>
<pub-id pub-id-type="pmid">15833376</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0074"><mixed-citation publication-type="journal" id="efs2e200915-cit-0074">
<string-name>
<surname>Soni</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Greenberg</surname>
<given-names>NA</given-names>
</string-name> and <string-name>
<surname>Burdock</surname>
<given-names>GA</given-names>
</string-name>, <year>2002</year>. <article-title>Evaluation of the health aspects of methyl paraben: a review of the published literature</article-title>. <source>Food and Chemical Toxicology</source>, <volume>40</volume>, <fpage>1335</fpage>&#x02013;<lpage>1373</lpage>. <pub-id pub-id-type="doi">10.1016/s0278-6915(02)00107-2</pub-id>
<pub-id pub-id-type="pmid">12387298</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0075"><mixed-citation publication-type="journal" id="efs2e200915-cit-0075">
<string-name>
<surname>Sonnenburg</surname>
<given-names>JL</given-names>
</string-name> and <string-name>
<surname>B&#x000e4;ckhed</surname>
<given-names>F</given-names>
</string-name>, <year>2016</year>. <article-title>Diet&#x02013;microbiota interactions as moderators of human metabolism</article-title>. <source>Nature</source>, <volume>535</volume>, <fpage>56</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nature18846</pub-id>
<pub-id pub-id-type="pmid">27383980</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0076"><mixed-citation publication-type="journal" id="efs2e200915-cit-0076">
<string-name>
<surname>Spanogiannopoulos</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bess</surname>
<given-names>EN</given-names>
</string-name>, <string-name>
<surname>Carmody</surname>
<given-names>RN</given-names>
</string-name> and <string-name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</string-name>, <year>2016</year>. <article-title>The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism</article-title>. <source>Nature Reviews Microbiology</source>, <volume>14</volume>, <fpage>273</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2016.17</pub-id>
<pub-id pub-id-type="pmid">26972811</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0077"><mixed-citation publication-type="journal" id="efs2e200915-cit-0077">
<string-name>
<surname>Tian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>A&#x02010;K</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dahlin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Waldor</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Weinstock</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Weiss</surname>
<given-names>ST</given-names>
</string-name> and <string-name>
<surname>Liu</surname>
<given-names>Y&#x02010;Y</given-names>
</string-name>, <year>2020</year>. <article-title>Deciphering functional redundancy in the human microbiome</article-title>. <source>Nature Communications</source>, <volume>11</volume>, <fpage>6217</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-19940-1</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0078"><mixed-citation publication-type="journal" id="efs2e200915-cit-0078">
<string-name>
<surname>Torres&#x02010;S&#x000e1;nchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pardo&#x02010;Cacho</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>L&#x000f3;pez&#x02010;Moreno</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ruiz&#x02010;Moreno</surname>
<given-names>&#x000c1;</given-names>
</string-name>, <string-name>
<surname>Cerk</surname>
<given-names>K</given-names>
</string-name> and <string-name>
<surname>Aguilera</surname>
<given-names>M</given-names>
</string-name>, <year>2021</year>. <article-title>Antimicrobial effects of potential probiotics of bacillus spp. isolated from human microbiota: in&#x000a0;vitro and in silico methods</article-title>. <source>Microorganisms</source>, <volume>9</volume>, <fpage>1615</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms9081615</pub-id>
<pub-id pub-id-type="pmid">34442694</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0079"><mixed-citation publication-type="journal" id="efs2e200915-cit-0079">
<string-name>
<surname>Tremaroli</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Karlsson</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Werling</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>St&#x000e5;hlman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kovatcheva&#x02010;Datchary</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Olbers</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>F&#x000e4;ndriks</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>le Roux</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Nielsen</surname>
<given-names>J</given-names>
</string-name> and <string-name>
<surname>B&#x000e4;ckhed</surname>
<given-names>F</given-names>
</string-name>, <year>2015</year>. <article-title>Roux&#x02010;en&#x02010;Y gastric bypass and vertical banded gastroplasty induce long&#x02010;term changes on the human gut microbiome contributing to fat mass regulation</article-title>. <source>Cell Metabolism</source>, <volume>22</volume>, <fpage>228</fpage>&#x02013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.009</pub-id>
<pub-id pub-id-type="pmid">26244932</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0080"><mixed-citation publication-type="journal" id="efs2e200915-cit-0080">
<string-name>
<surname>Trinh</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zaneveld</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Safranek</surname>
<given-names>S</given-names>
</string-name> and <string-name>
<surname>Rabinowitz</surname>
<given-names>PM</given-names>
</string-name>, <year>2018</year>. <article-title>One Health relationships between human, animal, and environmental microbiomes: a mini&#x02010;review</article-title>. <source>Frontiers in Public Health</source>, <volume>6</volume>. <pub-id pub-id-type="doi">10.3389/fpubh.2018.00235</pub-id>
</mixed-citation></ref><ref id="efs2e200915-bib-0081"><mixed-citation publication-type="journal" id="efs2e200915-cit-0081">
<string-name>
<surname>Ulluwishewa</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>McNabb</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Moughan</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Wells</surname>
<given-names>JM</given-names>
</string-name> and <string-name>
<surname>Roy</surname>
<given-names>NC</given-names>
</string-name>, <year>2011</year>. <article-title>Regulation of tight junction permeability by intestinal bacteria and dietary components</article-title>. <source>The Journal of Nutrition</source>, <volume>141</volume>, <fpage>769</fpage>&#x02013;<lpage>776</lpage>. <pub-id pub-id-type="doi">10.3945/jn.110.135657</pub-id>
<pub-id pub-id-type="pmid">21430248</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0082"><mixed-citation publication-type="journal" id="efs2e200915-cit-0082">
<string-name>
<surname>Valkova</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>L&#x000e9;pine</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bollet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dupont</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Villemur</surname>
<given-names>R</given-names>
</string-name>, <year>2002</year>. <article-title>prbA, a gene coding for an esterase hydrolyzing parabens in <italic toggle="yes">Enterobacter cloacae</italic> and <italic toggle="yes">Enterobacter gergoviae</italic> strains</article-title>. <source>Journal of Bacteriology</source>, <volume>184</volume>, <fpage>5011</fpage>&#x02013;<lpage>5017</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.18.5011-5017.2002</pub-id>
<pub-id pub-id-type="pmid">12193616</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0083"><mixed-citation publication-type="journal" id="efs2e200915-cit-0083">
<string-name>
<surname>Van den Abbeele</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Roos</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Eeckhaut</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>MacKenzie</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Derde</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Verstraete</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Marzorati</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Possemiers</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vanhoecke</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Van Immerseel</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Van de Wiele</surname>
<given-names>T</given-names>
</string-name>, <year>2012</year>. <article-title>Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli</article-title>. <source>Microbial Biotechnology</source>, <volume>5</volume>, <fpage>106</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-7915.2011.00308.x</pub-id>
<pub-id pub-id-type="pmid">21989255</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0084"><mixed-citation publication-type="journal" id="efs2e200915-cit-0084">
<string-name>
<surname>Wang</surname>
<given-names>Q&#x02010;P</given-names>
</string-name>, <string-name>
<surname>Browman</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Herzog</surname>
<given-names>H</given-names>
</string-name> and <string-name>
<surname>Neely</surname>
<given-names>GG</given-names>
</string-name>, <year>2018</year>. <article-title>Non&#x02010;nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice</article-title>. <source>PLoS One</source>, <volume>13</volume>, <elocation-id>e0199080</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0199080</pub-id>
<pub-id pub-id-type="pmid">29975731</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0085"><mixed-citation publication-type="book" id="efs2e200915-cit-0085">
<collab collab-type="authors">WHO (World Health Organization)</collab>
, <year>2015</year>. <source>Global Action Plan on Antimicrobial Resistance</source>. <publisher-name>World Health Organization</publisher-name>, <publisher-loc>Geneva</publisher-loc>.</mixed-citation></ref><ref id="efs2e200915-bib-0086"><mixed-citation publication-type="miscellaneous" id="efs2e200915-cit-0086">
<collab collab-type="authors">WHO (World Health Organization)</collab>
, <year>2021</year>. <article-title>Antimicrobial resistance</article-title>. Available online: <ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance</ext-link> [Accessed: 20 January 2022]</mixed-citation></ref><ref id="efs2e200915-bib-0087"><mixed-citation publication-type="journal" id="efs2e200915-cit-0087">
<string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Heinze</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cerniglia</surname>
<given-names>CE</given-names>
</string-name> and <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>, <year>2007</year>. <article-title>Anaerobic metabolism of 1&#x02010;amino&#x02010;2&#x02010;naphthol&#x02010;based azo dyes (Sudan dyes) by human intestinal microflora</article-title>. <source>Applied and Environmental Microbiology</source>, <volume>73</volume>, <fpage>7759</fpage>&#x02013;<lpage>7762</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01410-07</pub-id>
<pub-id pub-id-type="pmid">17933925</pub-id></mixed-citation></ref><ref id="efs2e200915-bib-0088"><mixed-citation publication-type="journal" id="efs2e200915-cit-0088">
<string-name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rey</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Trehan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Dominguez&#x02010;Bello</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Contreras</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Magris</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hidalgo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Baldassano</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Anokhin</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Heath</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Warner</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Reeder</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuczynski</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Caporaso</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Lozupone</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Lauber</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Clemente</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Knights</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>R</given-names>
</string-name> and <string-name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</string-name>, <year>2012</year>. <article-title>Human gut microbiome viewed across age and geography</article-title>. <source>Nature</source>, <volume>486</volume>, <fpage>222</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1038/nature11053</pub-id>
<pub-id pub-id-type="pmid">22699611</pub-id></mixed-citation></ref></ref-list></back></article>